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ABSTRACT

Mechanistic Insights into Diverse Protease Adaptor Functions

September 2021

Nathan James Kuhlmann, B.Sc., BENEDICTINE UNIVERSITY

Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST

Directed by: Professor Peter Chien

Protein degradation is an essential cellular process that helps maintain
proper homeostasis. The ClpXP protease broadly regulates bacterial
development and quality control during the cell cycle. The range and order of
substrates that ClpXP degrades during the cell cycle is dictated by 3 accessory
proteins, which are known as adaptors. This thesis will elaborate on how
dimerization tightly regulates the stability and activity of the adaptor protein at the
center of this hierarchy, RcdA, and show how this affects normal cellular
processes in Caulobacter crescentus. I will discuss the mechanism by which
dimerization limits RcdA activity and how the dimerization interface contains
selective regions that differentiate which substrates can engage with RcdA.
Lastly, I will discuss how RcdA and the master regulator of Caulobacter, CtrA,
interacts with the third adaptor in the hierarchy, PopA and the various surfaces
on the PopA adaptor that are involved in each interaction. The remainder of the
thesis will present data that arises from these projects.
ix

TABLE OF CONTENTS

Page

ACKNOWLEDGMENTS.................................................................................................. v
ABSTRACT.................................................................................................................... ix
LIST OF FIGURES ........................................................................................................ xii
CHAPTER
1.

An Overview of Adaptor-Dependent Protein Degradation and Regulation .... 1
1.1 Overview ........................................................................................................ 1
1.2 Adaptor-Dependent Proteases in Nature........................................................ 2
1.3 Specific Adaptors Tether or Prime Proteases for Delievery of Cargo ............. 5
1.4 A Hiearchy of Adaptors Drive Cell-Cycle Degradation
…………………………………….10
1.5 Adaptors are Broadly Degraded in the Absence of
Cargo………………………………....13
1.6 RcdA Dimerization and Cargo Binding Characteristics ................................ 15
1.7 Research Questions and Conclusions ......................................................... 18
1.8 Thesis Structure ........................................................................................... 19

2.

Cargo Competition for a Dimerization Interface Restricts and Stabilizes a

Protease Adaptor
2.1 Abstract........................................................................................................ 24
2.2 Main text ...................................................................................................... 25
2.3 Materials and Experimental Procedures ....................................................... 87
2.4 Acknowledgments and References .............................................................. 98

x

3.

Hydrogen Deuterium Exchange Mass Spectrometry Reveals Determinants

for PopA Activity and Function
3.1 Abstract ..................................................................................................... 106
3.2 Introduction ............................................................................................... 107
3.3 Results ....................................................................................................... 110
3.4 Discussion ................................................................................................. 134
3.5 Materials and Experimental Procedures ..................................................... 136
3.6 Acknowledgements and References .......................................................... 143

4.

Future Perspectives and Impact of Work On Protease Adapator Field
4.1 Overview .................................................................................................... 148
4.2 Impact of Thesis Work on Protease Adaptor Field ..................................... 149
4.3 CryoEM characterization of the ClpXP adaptor hiearchy ............................ 154
4.4 Structural characterization of RcdA-cargo interactions ............................... 155
4.5 Mechanistic characterization of CpdR function ........................................... 156
4.6 Identification of New Adaptor-Dependent Substrates and Pathways .......... 157

Appendix ........................................................................................................ 160
Bibliography ................................................................................................... 188

xi

LIST OF FIGURES
Figure

Page

Figure 1.1 Mechanism of Protease Function.................................................................... 4
Figure 1.2 Mechanism of Protease Adaptors ................................................................... 5
Figure 1.3 Mechanism of the Priming Adaptor CpdR ....................................................... 7
Figure 1.4 Mechanism of the Scaffolding Adaptor RcdA ................................................ 10
Figure 1.5 An Adaptor Hierarchy Controls Cell-Cycle Protein Degradation in Caulobacter
...................................................................................................................... 13
Figure 1.6 Adaptors are Degraded by their Proteases ................................................... 16
Figure 1.7 Dimerization Interface and Structure of RcdA ............................................... 19
Figure 1.8 RcdA Binds a Range of Cargo ...................................................................... 20
Figure 2.1 RcdA Directly Interacts with its Cargo by Analytical SEC .............................. 26
Figure 2.2 RcdA forms a Monomer when Bound to Cargo by SEC-MALS ..................... 28
Figure 2.3 RcdA binds SpbR as a Monomer by AUC..................................................... 31
Figure 2.4 SEC Coelution of RcdA-Cargo Complexes, related to Figure 2.2 ................. 33
Figure 2.5 ITC analysis of RcdA Dimerization and SpbR Binding .................................. 35
Figure 2.6 Additional measurements of SpbR-RcdA binding and RcdA
dimerization…………………..37
Figure 2.7 RcdA Cargo Competition Model ................................................................... 39
Figure 2.8 RcdA Heterodimerization Protects RcdA from Degradation .......................... 41
Figure 2.9 Alternative RcdA Dimer Interfaces ................................................................ 44
Figure 2.10 The L82E Variant Forms Monomers by SEC-MALS and FP ...................... 45
Figure 2.11 The L82E Variant is Incapable of being Degraded ...................................... 46
Figure 2.12 The L82E Variant is Selectively Defective in Cargo Binding by FP ............. 48
xii

Figure 2.13 The L82E Variant is Selectively Defective in Cargo Binding by SEC-MALS
and SEC ........................................................................................................ 50
Figure 2.14 The L82 Variant is Selectively Defective in Cargo Delivery ......................... 53
Figure 2.15 The L82E Variant Interacts with the ClpX:CpdR complex the same as
Wildtype ........................................................................................................ 55
Figure 2.16 A Crosslinked RcdA Dimer cannot Interact with PopA ................................ 57
Figure 2.17 The Dimerization Interface is Protected in the Presence of Cargo ............. 61
Figure 2.18 Mapping of the Solution RcdA Dimer Interface .......................................... 63
Figure 2.19 Additional Protected HDX Peptides ............................................................ 64
Figure 2.20 RcdA Sequence Alignment Reveals Conserved Residues.......................... 67
Figure 2.21 Illustration of the RcdA 3E Mutant............................................................... 68
Figure 2.22 The RcdA 3E Mutant is Selective for Cargo Binding ................................... 69
Figure 2.23 The RcdA 3E Mutant is Selective for Cargo Delivery .................................. 71
Figure 2.24 Expression of the L82E and 3E variants causes Stalk Formation Defects .. 73
Figure 2.25 The RcdA 3E Variant has Motility Defects .................................................. 75
Figure 2.26 The RcdA L82E and 3E Variants are Selective for Cargo Delivery In Vivo.. 77
Figure 2.27 The RcdA L82E Facilitates Faster Degradation of CtrA at Lower
Concentrations .............................................................................................. 79
Figure 2.28 The RcdA L82E Variant Reduces Cell Fitness and Delivers CtrA Faster In
Vivo ............................................................................................................... 80
Figure 2.29 Model of RcdA Binding and Delivery Mechanism ........................................ 83
Figure 3.1 PopA, CtrA, cdG and RcdA form a Ternary Complex by Nickel Pulldown
Assays ......................................................................................................... 113
Figure 3.2 RcdA interacts with the Second Receiver Domain by HDX-MS .................. 115
Figure 3.3 RcdA binds PopA and PopA-cdG with similar affinity ................................. 117
Figure 3.4 The first receiver domain of PopA is insufficient to bind RcdA .................... 118
Figure 3.5 RcdA Interacts with the Second Receiver Domain when cdG is Present .... 119
xiii

Figure 3.6 Cdg binding causes conformational changes in PopA by HDX-MS ............. 121
Figure 3.7 Activation curve of GFP-CtrA Degradation by cdG ..................................... 124
Figure 3.8 Sedimentation Velocity-AUC of PopA in the presence of cdG..................... 125
Figure 3.9 PopA and CtrA form a monomer:monomer stoichiometry by SEC-MALS ... 128
Figure 3.10 HDX Data from PopA-RcdA-CtrA Ternary Complex.................................. 131
Figure 3.11 Fluorescence Polarization CtrA Competition Assay .................................. 132
Figure 3.12 Model of PopA-CtrA-RcdA Complex and Delivery Mechanism ................. 133
Figure A.1 Uncropped degradation gels, related to Figure 2.11 ................................... 160
Figure A.2 Uncropped degradation gels, related to Figure 2.14, Figure 2.23 ............... 161
Figure A.3 Uncropped western blots, related to Figure 2.26 ........................................ 162
Figure A.4 SEC-MALS of the RcdA R131/5E variant ................................................... 164
Figure A.5 SEC-MALS of the L82A variant .................................................................. 165
Figure A.6 Serial titrations of RcdA on SEC-MALS ..................................................... 167
Figure A.7 Serial titrations of RcdA on AUC ................................................................ 168
Figure A.8 Preliminary NMR spectra of RcdA-cargo interactions ................................. 170
Figure A.9 Schrodinger modeled TacA peptide on RcdA crystal structure ................... 172
Figure A.10 Intrinisic tryptophan flouresence of the L82E variant ................................ 174
Figure A.11 Heterodimerization fluorescence polarization of RcdA variants ................ 176
Figure A.12 Differential scanning fluorimetry melt curves of RcdA variants ................ 178
Figure A.13 ITC Thermogram of L82E-PopA Interaction ............................................. 179
Figure A.14 GFP-DBDTacA Assays in the Presence of PopA-RD1 Truncation .............. 180
Figure A.15 CpdR-ClpX Binding Curves with Fluorescence RcdA and L82E ............... 181
Figure A.16 CpdR Kactivation Curve with GFP-DBDTacA ................................................... 182
Figure A.17 Agar motility assay of PrcdA::L82E and PrcdA::RcdADD............................... 183
Figure A.18 CtrA synchrony assays of PrcdA::RcdADD ................................................. 184
Figure A.19 PrcdA::RcdADD fitness competition assay .................................................. 185
Figure A.20 Phosphomycin spot assays of ΔrcdA strain .............................................. 186

xiv

CHAPTER 1
An Overview of Adaptor-Dependent Protein Degradation and Regulation
Parts of this introduction were as written by Kuhlmann, N.J. and Chien, P.,
published in Current Opinions in Microbiology 2017

1.1 Overview
The controlled degradation of proteins is a necessity for cellular development and
physiology. AAA+ (ATPases Associated with diverse cellular Activities) proteases
dictate the lifetime of proteins after translation, offering another layer of posttranslational control and recycling amino acids for metabolic networks in all
organisms. While there are few proteases in every organism, they contain the
capacity to completely change the balance of proteins in the cell at any given
point. In most cases, proteases themselves are also tightly regulated by
additional factors, be it small molecules, protein scaffolds, post-translational
modifications, or even degradation by themselves or other proteases. At the
center of my thesis is the question of how protein scaffolds, or adaptors regulate
which substrates are chosen to be degraded at the molecular level and how
degradation of adaptors affects cell physiology. I will go into detail into different
proteases that use adaptors to regulate their mechanism and substrate selection,
how adaptors can work in tandem to regulate substrate selection in a hierarchical
manner, how adaptors themselves are regulated post-translationally, and the
specific characteristics of my adaptor of focus, RcdA. Each of these topics drive
the research questions of my thesis project.
1

1.2 Adaptor-Dependent Proteases in Nature
Proteases are, on the surface, simple enzymes. Proteases typically consist of
two functional components: the unfoldase domain, which recognizes folded or
unfolded substrates by a short sequence motif, called a degron. After recognition
of this sequence, the AAA+ unfoldase module unravels the substrate through the
power of ATP hydrolysis into its primary structure, where the substrate is fed into
the proteolytic peptidase module (Figure 1.1), (Hanson and Whiteheart, 2005).
The unfoldase module is therefore responsible for the initial specificity of the
protease-substrate interaction. However, during specific stages of the cell-cycle
and during periods of stress, additional levels of specificity are needed to prevent
unwanted degradation and to prioritize certain substrates. In such cases,
proteases use additional proteins called adaptors to dictate substrate selection.
At the simplest level, a protease adaptor acts to select which substrates are
actively engaged with the unfoldase component of a protease (Figure 1.2).
Proteases that use adaptors are widespread in nature. The ClpXP protease,
found in bacteria and in human mitochondria (Baker and Sauer, 2011), makes
use of several adaptors to drive cell-cycle dependent protein degradation, the
function of which I will go into greater detail in section 1.4. For the Clp family of
proteases, there are several proteases that make use of specific adaptors to
regulate substrate choice. The ClpAP protease, which shares similarities to
ClpXP, uses the ClpS adaptor to prioritize N-end rule substrates (Erbse et al,
2006, Wang et al, 2007 and 2008). Similarly, in Bacillus subtilitis, the ClpCP
2

protease uses several adaptors, MecA, McsB, and YpbH, to regulate the
competency and sporulation of the bacterium by degrading factors such as
ComK and ComS (Schlothauer et al, 2003, Persuh et al, 2002, Kirstein et al,
2007). Interestingly, the assembly of the ClpC hexameric unfoldase is mediated
by interactions with MecA, suggesting that adaptors can act in other ways
besides direct substrate engagement to regulate protease function (Kirstein et al,
2006). Finally, the 26S proteasome uses adaptors such as Cic1 to recruit specific
proteins for proteasomal degradation (Jager et al., 2001). In each of these cases,
adaptors provide an additional layer of specificity and prioritization for the
protease substrate pool such that substrates of particular importance are
selectively degraded. For some adaptors such as MecA, the post-translational
state of the adaptor is modified by phosphorylation to control its function and this
has direct consequences on the physiology and development of the bacteria. The
additional layers of regulation that gate adaptor activity and stability is a central
theme of my thesis work and will be further explored in Chapters 2 and 3.

3

Figure 1.1: Mechanism of Protease Function.
AAA+ Proteases contain two functional modules: A hexameric unfoldase
chaperone, and a peptidase chamber that contains the proteolytic active site.
Through the power of ATP hydrolysis, the unfoldase portion engages substrates
through a short sequence recognition motif, then unfolds the substrate into the
peptidase chamber, where the protein is degraded into its amino acid
components.

4

Figure 1.2: Mechanism of Protease Adaptors.
Adaptor proteins work by limiting the protease to only degrading certain targets,
providing extra levels specificity to the substrate-unfoldase interaction. Many
adaptors interact with the substrates to bring them in proximity of the unfoldase,
where they are recognized and subsequently degraded.
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1.3 Specific Adaptors Tether or Prime Proteases for Delivery of Cargo
Parts of this section were taken from Kuhlmann, Chien 2017.
Adaptors typically fall into two modes of function: that of an active primer or that
of a passive scaffold. Adaptors that act as active primers prepare the protease
for substrate delivery, often by directly interacting with the protease before
interacting and delivering its cargo. In the case of the CpdR adaptor
from Caulobacter crescentus, binding of this protein to the unique N-domain of
the ClpX unfoldase prepares the protease for recognition of a class of substrates
(Figure 1.3), (Lau et al., 2015, Iniesta et al., 2006). Here, the adaptor does not
strongly interact with its cargo in the absence of the ClpX N-domain. This
preparation, or priming, of the protease could arise from conformational changes
in either CpdR or ClpX upon adaptor binding or could stem from a composite
interaction surface that is only present in the complex. Regardless of mechanism,
this type of priming function has features distinguishable from a simple scaffold.
For example, high concentrations of scaffolds such as SspB inhibit substrate
degradation because partial occupancy of the scaffold restricts simultaneous
binding of substrate and protease. By contrast, CpdR activity resists such
inhibition as the substrate binding activity is only present when the adaptor binds
the protease (Lau et al., 2015).
Similar types of priming functions have been observed with other adaptor
systems. Binding of the YjbH adaptor is required for Spx degradation by ClpXP in
gram-positive bacteria, but YjbH does not bind ClpX well on its own. Here, YjbH
6

binding unveils a C-terminal degron in Spx that is in turn recognized by ClpXP
(Chan et al, 2014). The RssB adaptor binds RpoS directly, but its weak binding to
ClpX suggests that priming of the substrate by the adaptor is needed for
protease recognition (Zhou et al., 2001, Studemann et al., 2003). Thus, it seems
that the ability of adaptors to activate either protease or substrate for eventual
degradation is a mechanism that has arisen in many systems.

7

Figure 1.3: Mechanism of the Priming Adaptor CpdR.
The CpdR adaptors acts a primer for the ClpXP protease. CpdR does not interact
with its substrates on its own, rather, it directly interacts with the N-terminal
domain of ClpX to prime ClpX for interactions with CpdR-dependent substrates.
While the mechanism of CpdR-dependent ClpX activation is currently unknown,
this mechanism might involve the formation of a new composite interface
between ClpX and CpdR that recruits CpdR-dependent substrates.
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The simplest mechanism for an adaptor is that of a passive scaffold. In these
cases, the adaptor directly interacts with its cargo outside of the presence of a
protease and increases the effective concentration of substrate that the
unfoldase module encounters. In doing so, the adaptor increases the relative
concentration of substrates to well past the KM of the protease by constraining the
volume of the substrate to make recognition events by the unfoldase module
happen more frequently. Adaptors that follow this function are the SspB adaptor,
which binds and delivers substrates tagged with the ssrA peptide appended to
proteins arising from failed translation events (Levchenko et al., 2000, Gottesman
et al., 1998). SspB acts as a constitutive adaptor as its levels are constant
throughout the bacterial life cycle (Farrell et al., 2005). Other adaptors that follow
this mechanism are ClpS (Erbse et al, 2006, Wang et al, 2007 and 2008), and
the RcdA (Regulator of CtrA Degradation) adaptor in Caulobacter crescentus
(Figure 1.4), (Joshi et al., 2015, McGrath et al, 2006), the adaptor of my research
focus in my thesis. In the next subchapter, I will go into the specific functions that
RcdA performs during the Caulobacter cell-cycle and how it coordinates its
delivery functions with additional adaptors.

9

Figure 1.4: Mechanism of the Scaffolding Adaptor RcdA.
The RcdA adaptor acts as a scaffold for CpdR and ClpXP. RcdA directly binds its
cargo, and upon interactions with a CpdR-primed ClpXP, can scaffold its
substrates to ClpX for unfolding and subsequent degradation. RcdA’s function as
a scaffold increases the relative substrate concentration by constraining the
volume that the pool of substrate occupies, allowing for ClpX to encounter a
higher effective concentration of substrate and consequentially result in more
unfolding events.
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1.4 A Hierarchy of Adaptors Drive Cell-Cycle Protein Degradation in
Caulobacter crescentus
Proteases make use of adaptors during cellular transitions and during times of
stress. In Caulobacter crescentus, the ClpXP protease makes uses of a
hierarchy of adaptor proteins to dictate substrate degradation during the
developmental transition from a motile swarmer developmental state to a sessile
stalked developmental state. During the G1 to S transition in the Caulobacter life
cycle, ClpXP degrades a series of key regulatory proteins that include
chemoreceptors involved in cell motility (Bhat et al., 2013, Tsai et al., 2001) and
several replication and transcription factors critical for promoting proper cell cycle
and developmental control (Quon et al., 1996, Gora et al., 2013, Biondi et al.,
2006, Gorbatyuk et al, 2005). While the ClpXP is capable of degrading important
cell cycle independent substrates such as DnaX (Vass et al., 2013), ClpXP
requires one or more adaptors for all substrates that are degraded in a cell-cycle
dependent manner (Bhat et al., 2013, Joshi et al, 2015, Lau et al., 2015). During
the Caulobacter cell-cycle, ClpXP makes use of 3 adaptors and oscillating levels
of the small molecule cyclic-di-GMP (cdG) to dictate which substrates are
degraded (Figure 1.5). During G1, the first adaptor, CpdR, binds to the Nterminal domain of ClpX, allowing the degradation of a class of substrates
specific to CpdR, including the phosphodiesterase PdeA, which downregulates
the levels of cdG (Lau et al., 2015). Only after CpdR is assembled on ClpXP can
the second adaptor, RcdA, bind via its C-terminal tail to CpdR and deliver a class
11

of substrates that includes the σ54 transcription factor TacA, which is involved
regulating genes involved in stalk biogenesis (Biondi et al., 2006, Joshi et al.,
2015), and the pole-localized protein SpbR, which is implicated in inhibiting
centromere translocation (Wang et al., 2019). After the assembly of CpdR and
RcdA onto ClpX, the third adaptor, PopA (Duerig et al., 2009, Ozaki et al., 2014),
binds the small molecule cdG and RcdA to deliver its own class of substrates,
which include the replication inhibitor CtrA (Quon et al., 1996, Smith et al., 2014).
This hierarchical proteolysis provides precise timings of degradation coupled to
the tight regulation of cdG levels to provide several layers of regulation of this
important signaling pathway in Caulobacter. The use of several adaptors appears
to be present in Eukaryotic organelles as well, as the ClpF and ClpS1 adaptor
complex is necessary for the regulated degradation of GluTR, a critical enzyme
involved in tetrapyrrole synthesis in chloroplasts (Nishimura et al., 2015). The
presence of several multi-adaptor systems indicates the necessity for various
levels of regulation when delivering key protein targets, suggesting that other
proteolytic machines may have these adaptor hierarchies in place that as of yet
unknown. At the center of the Caulobacter adaptor hierarchy is RcdA, which
coordinates binding between CpdR, PopA and the range of cargo it delivers to
ClpXP. The broad focus of my thesis is understanding how RcdA and other
adaptors in this pathway function mechanistically. In the following subchapters, I
will go into detail into how RcdA degradation (Joshi et al., 2017) and RcdA
dimerization and regulation (McGrath et al., 2006, Taylor et al., 2009, Joshi et al.,
12

2015) are fundamental properties that drive the major research questions of my
thesis project.

13

Figure 1.5: An Adaptor Hierarchy Controls Cell-Cycle Protein Degradation
in Caulobacter
A series of adaptors controls cell-cycle degradation in Caulobacter. The
developmental transition from a motile swarmer cell in G1 to a sessile stalked cell
during the onset of S-phase and DNA replication is regulating by adaptordependent protein degradation. The first adaptor, CpdR, binds ClpX and delivers
a class of substrates. The second adaptor, RcdA, binds to a CpdR-primed ClpX
and delivers its class of substrates. Finally, the third adaptor, PopA, binds the
small molecule cdG and RcdA, facilitates the degradation of CtrA, and DNA
replication takes place following CtrA degradation.
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1.5 Adaptors are Broadly Degraded in the Absence of Cargo
A critical conundrum exists for adaptors: what happens after they perform their
delivery jobs? While not actively delivering cargo, many of these adaptors run the
risk of being degraded by their respective proteases (Figure 1.6). Experimental
evidence has shown that adaptors like MecA and HspQ themselves are
degraded by their respective proteases, suggesting that adaptor degradation is a
broadly conserved phenomenon (Puri et al., 2017, Turgay et al., 1998). In
Caulobacter, Previous studies have shown that several ClpXP adaptors in
Caulobacter, including RcdA, SspB and CpdR are specifically degraded by
ClpXP (Joshi et al., 2017). Surprisingly, PopA does not appear to be degraded by
ClpXP despite CpdR and RcdA being substrates for the protease. Interestingly,
RcdA is stabilized in the presence of cargo and only appears to be degraded
when there is not cargo present (Joshi et al., 2017). Nondegradable variants of
RcdA substrates, such as TacADD and SpbRDD, are sufficient to protect RcdA
from degradation, suggesting that the act of RcdA binding to cargo itself is
responsible for this protection. The precise mechanism for this phenomenon is
unknown, as it appears that only native degradation tags cause this stabilization
(Joshi et al., 2017). My thesis work will provide an explanation for how cargo
binding causes stabilization of RcdA and the biological consequences of RcdA
degradation.
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Figure 1.6: Adaptors are Degraded by their Proteases
Adaptors run the risk of degradation in the absence of cargo. In the case of the
ClpXP adaptor hierarchy, adaptors are protected from degradation while
delivering cargo (right cartoon). Because each adaptor physically interacts with
parts of the protease, the degradation motif is near ClpX. Binding of cargo
prevents degradation of each adaptor until its delivery responsibilities are
completed.
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1.6 RcdA Dimerization and Cargo Binding Characteristics
In this section, I will go into detail about the history of experimental
characterization of RcdA to give context into the research questions I explore in
my thesis work. RcdA was discovered by mining previously published genomic
datasets to find gene candidates that potentially regulate CtrA function (McGrath
et al., 2006). Deletion of the RcdA gene from the Caulobacter genome leads to
stabilization of CtrA during the cell cycle, improper stalk formation and cell
motility on swarm agar, and a G1 cell cycle arrest when CtrA is not being
redundantly controlled by phosphorylation (McGrath et al., 2006). In 2009, RcdA
was crystallized and biochemically characterized in solution as a homodimer with
a disordered C-terminal tail, removal of which results in the inability to deliver
CtrA (Taylor et al., 2009). The dimer interface of RcdA (Figure 1.7) is broad and
covers many conserved hydrophobic and charged residues which I will explore in
detail in chapter 2. Following the work from Taylor et al., detailed characterization
of RcdA was performed to determine how RcdA regulates ClpXP substrate
degradation during the cell cycle (Joshi et al., 2015). In this work, an affinity
pulldown mass-spectrometry approach was used to identify additional cargo of
RcdA, revealing the breadth of cargo that RcdA interacts with (Figure 1.8, Joshi
et al., 2015). In addition to binding CpdR and PopA, the other adaptors in the
hierarchy, RcdA is capable of directly binding several cargo in solution, such as
SpbR and TacA, and tether those cargo to a CpdR-primed ClpXP for degradation
during the cell cycle. While it is clear by biochemical data that RcdA can directly
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interact with its cargo, it is unclear how RcdA can accommodate such a wide
range of cargo and whether RcdA dimerization plays a role in binding.

Figure 1.7: Dimerization Interface and Structure of RcdA
Two orientations of the published crystal structure of RcdA (PDB: 3ctw) with one
subunit represented as a surface projection and the other subunit represented by
a cartoon projection. The PDBePISA prediction of the dimer interface is
highlighted in yellow.

19

Figure 1.8: RcdA Binds a Range of Cargo
RcdA functions by directly interacting with direct substrates, such as TacA and
SpbR, and interacting with other adaptors such as PopA. To deliver cargo to
ClpXP, RcdA must interact with CpdR via its C-terminal tail.

20

1.7 Research Questions and Conclusions
The broad, overarching questions that my thesis was designed to answer involve
RcdA and its mechanism. First, how does RcdA interact with such a wide range
of cargo? While we know that RcdA is responsible for delivering at least 3 cargo
to ClpXP for degradation (Joshi et al., 2015), none of these cargoes share any
obvious sequence or fold motifs that indicate a conserved module that RcdA
recognizes. How does RcdA accomplish this task while also performing its critical
cell cycle responsibilities? While performing its delivery tasks, RcdA must also
have a functional mechanism to protect itself from degradation when bound to
cargo. How does RcdA accomplish this task? It is clear from structural and
biochemical data that RcdA forms a homodimer (Taylor et al., 2009). Does
dimerization play an important role in RcdA function, or is RcdA dimerization
simply an artifact of crystallization? More broadly, my thesis aims to answer how
RcdA coordinates binding between the third adaptor, PopA, to regulate CtrA
degradation. The work presented in this thesis will highlight new mechanisms by
which adaptor proteins regulate the bacterial cell cycle and explore new ways to
characterize adaptor function. However, the field of adaptors and scaffolds
requires new tools and screens to identify new adaptors and adaptor-dependent
substrates. For identifying new adaptors, it is more challenging. RcdA was
originally identified as a regulator of CtrA degradation, and through serendipity,
was discovered to be an adaptor for TacA degradation. Creative genetic and
biochemical screens are needed to help identify new adaptors and provide a
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framework for adaptor discovery projects, as it seems clear that adaptor proteins
play a critical role in regulating bacterial and organelle physiology. Advances in
quantitative proteomics, combined with the ability to synchronize different cell
populations of Caulobacter, will allow more rigorous and systematic identification
of new adaptor-dependent substrates. Generation of specific allelic mutations in
adaptors that differentially affect specific classes of substrates and specific
phenotypes will help identify new substrate candidates that can be validated
biochemically or genetically by narrowing the available substrate pool.
1.8 Thesis Structure
The second chapter of this thesis will describe my work in elucidating the
mechanism behind RcdA function and its biological significance. The third
chapter will describe my work in identifying the surfaces on PopA that are
involved in RcdA and CtrA interactions and degradation. The fourth chapter will
discuss lessons I’ve learned from my thesis work and provide future directions for
the field of protease adaptors. In the appendix I will provide any unpublished
results arising from the 2nd and 3rd chapters.
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2.1 Abstract
Bacterial protein degradation is a regulated process aided by protease adaptors
that alter specificity of energy dependent proteases. In Caulobacter crescentus,
cell-cycle dependent protein degradation depends on a hierarchy of adaptors, such
as the dimeric RcdA adaptor which binds multiple cargo and delivers substrates to
the ClpXP protease. RcdA itself is degraded in the absence of cargo and how
RcdA recognizes its targets is unknown. Here we show that RcdA dimerization and
cargo binding compete for a common interface. Cargo binding separates RcdA
dimers and a monomeric variant of RcdA fails to be degraded, suggesting that
RcdA degradation is a result of self-delivery. Based on HDX-MS studies showing
that different cargo rely on different regions of the dimerization interface, we
generate RcdA variants that are selective for specific cargo and show cellular
defects consistent with changes in selectivity. Finally, we show that masking of
cargo binding by dimerization also limits substrate delivery to restrain overly prolific
degradation. Using the same interface for dimerization and cargo binding offers
an ability to limit excess protease adaptors by self-degradation, while providing
capacity for binding a range of substrates.
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2.2 Introduction
This chapter describes our effort to elucidate how RcdA engages its cargo. Initial
studies showed that RcdA is a homodimer in solution and binds directly to its
cargo using several biochemical assays, including size-exclusion
chromatography (SEC) and fluorescence polarization (FP) experiments (Taylor et
al., 2009, Joshi et al., 2015). Initial characterization of RcdA-cargo complexes by
analytical SEC confirmed that RcdA binds it cargo, resulting in a higher molecular
weight species (Figure 2.1). However, it remained unclear based on the
uncertainty coming from the protein standards used in analytical SEC
experiments what the exact stoichiometry between RcdA and its cargo was and
whether this stoichiometry was consistent for all RcdA cargo. Our expectation,
based on prior work with the dimeric ClpXP adaptor SspB showing that optimal
delivery is achieved when two molecules of substrate are bound to a distal site
on SspB (Chien et al., 2007, McGinness et al., 2007, Bolon et al., 2004), was that
RcdA would share a similar mechanism. Due to the limitations of analytical SEC,
we were worried that reported masses would be inaccurate due to the
dependence on internal standards that do not consider protein shape, a common
pitfall in analytical SEC experiments. We decided to use sensitive biophysical
techniques that take absolute measurements of mass to fully characterize the
stoichiometry of RcdA-cargo complexes.
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Figure 2.1: RcdA Directly Interacts with its Cargo by Analytical SEC
A) Analytical SEC of RcdA and SpbR. 25µM RcdA (black), 25µM SpbR alone
(blue), or 25µM RcdA and SpbR together (red) were incubated for 45
minutes and ran over a 3mL analytical SEC column. B) Analytical SEC of
RcdA and the DNA-binding domain of TacA (Joshi et al., 2015). 25µM RcdA
(black), 25µM DBDTacA (blue) or 25µM RcdA and 25µM DBDTacA together
were incubated and ran over a 3mL analytical SEC column.
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2.3 RcdA Binds its Cargo as a Monomer
We began our studies by exploring RcdA-cargo binding using size-exclusion
chromatography with multi-angle light scattering (SEC-MALS) to measure
absolute molar mass. SpbR, a RcdA-dependent cargo responsible for inhibiting
centromere translocation (19) is a 42 kDa monomer in solution, while as expected,
the molar mass of RcdA is a dimer (36 kDa, Figure 2.2). The combination of both
proteins results in a complex with a determined mass of 61 kDa (Figure 2.2). Our
data is consistent with a monomer of RcdA (17 kDa) binding a monomer of SpbR
(44 kDa) and inconsistent with a dimer of RcdA binding a monomer of SpbR (a
predicted mass of 77 kDa) (Table 1). We confirmed this monomer:monomer
stoichiometry by using analytical ultracentrifugation and found a similar mass of 60
kDa for the RcdA:SpbR complex (Figure 2.3).
We next tested other RcdA cargo. PopA, the RcdA-binding adaptor, shows an
experimental mass of 41 kDa (Figure 2.2). In the presence of RcdA, the complex
mass is 58 kDa consistent with a monomer of PopA (41 kDa) binding a monomer
of RcdA (17 kDa) (Figure 2.2; Table 1). TacA, a transcription factor involved in
stalk biogenesis, has an experimental molar mass consistent with a dimer (124
kDa). When bound to RcdA, the complex shows an apparent mass of 141 kDa,
again consistent with a monomer of RcdA binding to a dimer of TacA (Figure 2.2;
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Figure 2.2: RcdA forms a Monomer when Bound to Cargo by SEC-MALS
A) SEC-MALS traces of different RcdA-cargo complexes. Representative SECMALS traces of the RcdA, cargo, and the RcdA-cargo complexes. Left axes show
normalized absorbance traces, right axes show calculated molecular weight in
kilodaltons. Dashed lines connect the scattering traces of the proteins/complexes
with the calculated molecular weights as labeled. The colored lines under each
peak represent the collected light scattering data as a distribution of molecular
weights over the width of the chromatography peak. Numbers represent the
calculated molecular weight from the scattering data. Concentrations of each
component and complex are noted in the methods section.
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Table 1: Cargo Binding Competes with RcdA Dimerization.

RcdA

Experimental (kDa)
(±4 kDa)

Stoichiometry

Predicted (kDa)

36

RcdA2 (dimer)

37

RcdA (monomer)

19

SpbR

42

SpbR (monomer)

43

RcdA + SpbR

61

RcdA:SpbR

62

TacA

124

TacA2 (dimer)

127

RcdA + TacA

141

RcdA:TacA2

146

PopA

41

PopA (monomer)

47

RcdA + PopA

58

RcdA:PopA

66

Table of molecular weights of the different RcdA-cargo complexes. The
experimental column shows the complex mass measured by SEC-MALS. The
stoichiometry column gives the stoichiometry of each protein consistent with the
experimental mass. The predicted column lists the EXPASY predicted mass of
each stoichiometry listed. Bolded text is the experimentally measured complex
masses displayed in Figure 1.
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Figure 2.3: RcdA Binds SpbR as a Monomer by AUC
Sedimentation constants fitted from velocity ultracentrifugation of the
RcdA- pbR complex. Each component was present at 25μM, either or
alone or in complex.
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Table 1). Strangely, despite having more mass than RcdA, we noticed that both
PopA and SpbR elute after RcdA on our SEC columns, which we attribute to nonspecific interactions with the stationary phase of our column or that PopA and
SpbR have different physical shapes than the RcdA dimer. We confirmed the
presence of both cargo and adaptor in these complexes by SDS-PAGE (Figure
2.4).
Our observation that RcdA binds it cargo as a monomer posed an interesting
thermodynamic conundrum: if RcdA dissociation occurs with a slow off-rate or with
a relatively tight binding constant, how does cargo binding outcompete RcdA
dimerization? We answered this question by measuring the binding affinity of RcdA
to cargo and to itself using several approaches. Using isothermal calorimetry, we
determined that the dimerization constant of RcdA (KD = 7 µM, Figure 2.5) and
dissociation constant between RcdA and SpbR (KD = 1 µM, Figure 2.5) were of
similar order. Measurements with a labeled RcdA reporter using fluorescence
polarization also revealed similar magnitudes for dimerization (K D = 2.5 µM) and
SpbR binding (KD = 2.1 µM), (Figure 2.6). Finally, microscale thermophoresis
measurements provides additional confirmation that RcdA binds itself and SpbR
with similar ranges of affinity (RcdA-SpbR complex (average KD = 5 µM);
dimerization (average KD = 3 µM)), (Figure 2.6).
Taken together, these data suggest that RcdA binds cargo as a monomer and that
binding of cargo competes with dimerization with similar binding affinities (Figure
2.7).
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Figure 2.4: SEC Coelution of RcdA-Cargo Complexes, related to Figure 2.2
In this figure, we have replicated all of the complexes shown in Figure 2.2 and
collected fractions for SDS-PAGE gel analysis. We used the chromatography
setup used in the SEC-MALS experiments and collected fractions by
disconnecting the light scattering detector which collects the waste and feed the
output in hand fractionated tubes. We show the A280 signal from chromatograms
of each complex and the gel profile of selected fractions for each chromatogram
on the right. Fraction numbers are shown above the graph. Loaded fractions are
numbered above each gel well, with the first lane showing the input sample
before SEC analysis. Fractions were loaded with more volume (17uL) than the
input samples (9uL) to account for dilution from the SEC column. The
concentrations used were the same as the concentrations used in Figure 1 and
this is noted in the methods section.
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Our data showing that RcdA dimers dissociate into monomers to bind all its cargo
(Figure 2.3) was surprising and opened the door for further exploration of
hypotheses regarding RcdA mechanism. One apparent hypothesis that came from
this observation was that the monomeric form of RcdA is responsible for its
stabilization when bound to cargo (Joshi et al., 2017). Our biophysical data
showing monomeric RcdA binding cargo would explain the stabilization caused by
the introduction of a nondegradable form of cargo (SpbRDD, TacADD or PopA),
since all three of these cargoes caused dissociation of RcdA into a monomeric
species.
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Figure 2.5: ITC analysis of RcdA Dimerization and SpbR Binding
B) Representative ITC thermogram of the heat of RcdA dissociation, heats of
injection shown on top. The sample syringe was loaded with 400μM RcdA and
titrated into a cell containing buffer. Kdimerization values are the average of three
independent

replicates

with

error

representing

standard

deviation.

C)

Representative ITC thermogram of the SpbR-RcdA complex formation, heats of
injection shown on top.
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Figure 2.6: Additional biophysical measurements of SpbR-RcdA binding
and RcdA dimerization, related to Figure 2.5
A) Microscale thermophoresis graph showing a titration of SpbR into labeled
RcdA. A serial dilution of unlabeled pbR starting at 30 μM was titrated into 200
nM labeled RcdA. The average of three independent experiments and the
standard deviation representing error are shown. B) Microscale thermophoresis
graph showing a titration of RcdA into labeled RcdA. A serial dilution of unlabeled
RcdA starting at 00 μM was titrated into 200 nM labeled RcdA. The average of
three independent experiments and the standard deviation representing error are
shown. C) Additional replicates of Dimerization ITC. Experimental setup, buffers
and concentration are the same as performed in Figure 1B. D) Additional
replicates of RcdA-SpbR binding ITC. Experimental setup, buffers and
concentration are the same as performed in Figure 1C.
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Figure 2.7: RcdA Cargo Competition Model
Cartoon illustrating the competition between dimerization and cargo binding. All
RcdA concentrations are in terms of monomeric equivalents unless otherwise
noted.
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2.4 Heterodimerization of RcdA slows RcdA Autodegradation
Our initial hypothesis that RcdA autodegradation suppression in the presence of
cargo is due to monomerization of RcdA came with two implications: that one
subunit of RcdA is insufficient for RcdA degradation and that one copy of the Cterminal tail is also insufficient for degradation. We sought to devise a system
where we could generate a heterodimer of RcdA that contains one subunit with a
C-terminal tail and another subunit that lacks a C-terminal tail. Because the Cterminal tail of RcdA is necessary for RcdA degradation (Joshi et al., 2017) we
hypothesized that we could form a heterodimer of RcdA that consist of one
subunit of WT RcdA and one subunit of RcdAΔC by mixing both species. If our
hypothesis that both subunits of RcdA are needed for RcdA degradation, then
our heterodimeric RcdA complex lacking one wildtype subunit should be
protected from degradation. Consistent with this hypothesis, addition of excess
RcdAΔC suppressed RcdA degradation in the presence of CpdR and ClpXP
(Figure 2.8). While this data is consistent with a model where monomeric RcdA is
protected from degradation, we sought to test this model by generating a
monomeric variant of RcdA.
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Figure 2.8: RcdA Heterodimerization Protects RcdA from Degradation
RcdA degradation at a final concentration of µM in vitro is inhibited in the
presence of excess ( 0µM) RcdAΔC. A representative gel and quantifications of
triplicates are shown below. A cartoon illustrating the heterodimer complex is
shown on the left.
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2.5 Generation of a Monomeric Variant of RcdA
To specifically test how a monomer of RcdA affects it function, we sought to
generate a monomeric variant of RcdA. During our initial attempts to cocrystallize RcdA with a TacA peptide to characterize RcdA:cargo interactions, we
crystallized the apo form of RcdA in a different packing conformation than what
was previously published in the original crystal structure (Crystallography
completed by Madeleine Sutherland). Based on the published crystal structure of
RcdA (Taylor et al., 2009, PDB: 3CTW) and our own in-house solved structure of
RcdA, there were two distinct dimer interfaces that were annotated. In the
published crystal structure, there were several amino acids that contain the
highest percentage of buried surface area in the predicted dimer interface as
predicted by the PDB PISA server for macromolecular interfaces. We identified
leucine 82 (L82) as a residue that had the highest buried surface area
percentage by the PDB PISA server as a candidate for mutation (Figure 2.9). In
the second interface found in our in-house solved structure, we identified
residues Arginine 131 and 135 (R131 and R135) as important residues in that
interface (Figure 2.9). We mutated L82 to glutamic acid (L82E) and alanine
(L82A) and R131 and R135 to glutamic acids (R131/5E) to disrupt each
interface. We purified both proteins and ran them and performed SEC-MALS to
confirm the molecular mass of each species. While the RcdA131/5E and L82A
variants ran as a dimer species that coeluted with WT RcdA (Figures A.4-A.5),
suggested this variant does not form a monomer, the RcdA L82E variant ran
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after WT RcdA and had a mass consistent with a monomeric species of RcdA
(19kDa, Figure 2.10). We confirmed that RcdA L82E is incapable of forming a
dimer by using fluorescence polarization as a readout of dimerization. While
wildtype RcdA was capable of increasing polarization when added to a
fluorescently labeled RcdA reporter, suggesting heterodimerization, RcdA L82E
did not show the same trend (Figure 2.10). Finally, we tested our hypothesis that
a monomeric form of RcdA is incapable of being degraded by testing whether
RcdA L82E could be degraded in vitro and in vivo. Consistent with our model,
RcdA L82E was stable in vitro throughout the time course of a degradation assay
similarly to a cargo-stabilized WT RcdA (Figure 2.11). Similarly, RcdA L82E was
not turned over in vivo in a translational shutoff assay when expressed from the
xylose promotor in a ΔrcdA strain background (Figure 2.11).

43

Figure 2.9: Alternative RcdA Dimer Interfaces and Residues Important for
Packing
A) Annotated dimer interface from originally published RcdA crystal structure
(Taylor et al., 2009, PDB 3ctw). Leucine 82 is highlighted as yellow
spheres in both subunits for visualization. B) Annotated dimer interface
from in-house solved RcdA structure (unpublished). Arginines 131 and
135 are highlighted as residue-colored spheres in both subunits for
visualization.
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Figure 2.10: The L82E Variant Forms a Monomer by SEC-MALS and
Fluorescence Polarization
A) The L82E variant forms a monomeric protein (grey trace) compared to WT
RcdA (black trace) by SEC-MALS. A PymoL illustration of the L82 residue
is shown on the left. B) Fluorescence polarization reporting on RcdA
dimerization. 20μM unlabeled RcdA and RcdA L82E was added to each
labeled reporter at 200nM.
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Figure 2.11: The L82E Variant is Incapable of Being Degraded
A) In vitro gel-based degradation of 3 µM RcdA alone, 3 µM RcdA with 3 µM
SpbRDD, or 3 µM RcdA L82E alone. Quantification of three independent replicates
is shown on the right, error bars represent standard deviation..B) Chloramphenicol
shutoff assays monitoring the degradation of RcdA and RcdA L82E in cells
expressing wildtype RcdA or RcdA L82E. Quantification of the average of 3
biological replicates are shown at right.
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2.7 The L82E Variant is Defective in Some Cargo Binding and Delivery
Our generation of a stable monomeric variant of RcdA allowed us to test directly
whether the interface used for dimerization was the same interface used for cargo
binding. We next tested the ability of RcdA L82E to bind and deliver different RcdA
cargo. SpbR and TacA are substrates of ClpXP that require RcdA for efficient
degradation, while PopA is an adaptor that binds RcdA to expand its substrate
profile (Duerig et al., 2009, Ozaki et al., 2014). We used wildtype RcdA or RcdA
L82E labeled with fluorescein and fluorescence polarization as a proxy for cargo
binding. Using this assay, we found that wildtype RcdA bound all three cargo (n.b.,
DBDTacA

is the minimal domain of TacA needed for RcdA degradation) (Figure

2.12). The monomeric RcdA L82E was unable to form a complex with SpbR and
DBDTacA,

but surprisingly, bound PopA with affinity equivalent to wildtype RcdA

(Figure 2.12). SEC-MALS and SDS-PAGE analysis of fractions confirmed these
changes in cargo binding (Figure 2.13).

47

48

Figure 2.12: The L82E Variant is Selectively Defective in Cargo Binding by
Fluorescence Polarization
A) Fluorescence polarization of labeled RcdA (black) or RcdA L82E (grey) in
the presence of SpbR, DBDTacA and PopA. 100nM of each labeled reporter
was incubated with 20μM cargo for 45 minutes and the polarization of
labeled RcdA or RcdA L82E was measured, three independent replicates
are shown with average and standard deviation. B) Fluorescence
polarization curves of the PopA-RcdA or PopA-RcdA L82E complex. A
serial dilution of unlabeled PopA starting at 40μM was titrated into 200nM
labeled RcdA or 200 nM labeled RcdA L82E.
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Figure 2.13: The L82E Variant is Selectively Defective in Cargo Binding by
SEC-MALS and Analytical SEC
A) Representative SEC-MALS chromatograms of RcdA L82E in the presence of
SpbR or PopA. Wildtype RcdA incubated with SpbR, PopA alone, and RcdA
L82E alone are shown for comparison. The colored lines under each peak
represent the collected light scattering data as a distribution of molecular weights
over the width of the chromatography peak. Numbers represent the calculated
molecular weight from the scattering data. B) Chromatograms and SDS-PAGE
gels of collected fractions of complexes shown in Figure 2.13. Fraction numbers
are shown above the graph and each gel. Loaded fractions are numbered above
each gel well, with the first lane showing the input sample before SEC analysis.
Concentrations used were the same as the experiments used in Figure 2.13.
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Consistent with the defects in SpbR and TacA binding, the RcdA L82E variant
showed less stimulation of the CpdR-ClpXP mediated degradation of these
substrates in vitro (Figure 2.14). This deficiency was not due to a failure of RcdA
L82E to bind the CpdR-ClpX complex, as fluorescence polarization assays that
monitor ClpX:CpdR:RcdA ternary complex formation (Joshi et al., 2015) showed
that both RcdA variants were able to bind the ClpX:CpdR complex with similar
affinity (Figure 2.15)
PopA binds RcdA directly, and in a c-di-GMP dependent manner promotes
degradation of CtrA (Smith et al., 2014, Ozaki et al., 2014). To test the effects on
PopA-mediated substrate delivery, we used a GFP reporter fused to the minimal
domains of CtrA needed for regulated degradation (GFP-CtrARD+15), (Smith et
al., 2014). Unlike the case for TacA or SpbR, the RcdA L82E variant was capable
of stimulating PopA-mediated CtrA degradation (Figure 2.14). These data show
that disrupting the dimer interface of RcdA reduces binding to some substrates,
but this monomeric variant can still bind to an activated ClpXP and deliver
permissive substrates (such as CtrA). Consistent with an overlap in interfaces for
cargo and dimerization, locking RcdA into a dimer by crosslinking also prevents
cargo binding, while L82E treated with the same concentrations of glutaraldehyde
did not affect the L82E variant’s ability to bind PopA (Figure 2.16) Taken together
with the observation that all cargoes can compete with RcdA dimerization, our
emerging model is that different substrates rely on different regions of the RcdA
dimer interface.
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Figure 2.14: The L82E Variant is Selectively Defective in Cargo Delivery
A) In vitro gel-based degradation assay of SpbR or in the presence of RcdA
or RcdA L82E. Full gels are shown in SI Appendix Fig. S3. Quantification
of three independent replicates showing means and error bars (standard
deviation). B) In vitro fluorescence degradation assay of GFP-CtrARD+15
in the presence of RcdA or RcdA L82E. Each fluorescence trace is the
average of three independent replicates with error bars showing standard
deviation. C) GFP-DBDTacA reporter degradation curves with RcdA and
RcdA L82E. Fits are to a modified hyperbolic equation as outlined in the
methods. D) GFP-CtrA reporter degradation curves with RcdA and RcdA
L82E. Fits are to a modified hyperbolic equation as outlined in the methods.
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Figure 2.15: The L82E Variant Interacts with the ClpX:CpdR Complex with
Same Affinity as WT RcdA
A) Illustration of polarization assay for measuring binding to CpdR-ClpX. A
fluorescently labeled RcdA variant increases fluorescence polarization
signal when bound to the CpdR-ClpX complex because of decreased
rotation. B) Fluorescence polarization of 200 nM RcdA and RcdA L82E
increase only with CpdR, ClpX, and ATPgS present. C) Competition of
fluorescently labeled RcdA L82E from the CpdR-ClpX complex by
unlabeled wildtype or L82E RcdA variants show they bind to the CpdRClpX complex equally well (IC50 = 5 µM). The fluorescent monomeric
RcdA L82E was used to prevent formation of dimers of unlabeled and
labeled RcdA, which would confound the readout.
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Figure 2.16: A crosslinked RcdA Dimer Cannot Interact with PopA
A) Coomassie stained SDS-PAGE gels of crosslinked 100μM RcdA and L82E
after incubation with increasing concentrations of glutaraldehyde, demonstrating
formation of a dimeric species. The asterik on the L82E crosslinking gel indicates
a higher molecular weight band that did not travel through the gel matrix. B) (left)
Illustration of assay to determine binding of RcdA to PopA using a fluorescently
labeled RcdA L82E. PopA binding to fluorescently labeled RcdA L82E results in
high polarization of the RcdA L82E reporter. Native RcdA will bind PopA
resulting in free labeled RcdA L82E which has a low polarization signal. (right)
Polarization signal from labeled RcdA L82E in the presence of the indicated
components. Note that wildtype RcdA causes a decrease in polarization, while
crosslinked RcdA does not, showing that locked RcdA dimers cannot bind cargo.
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2.8 The dimer interface is protected from exchange in the presence of
cargo
To determine how different cargoes interact with RcdA, we used hydrogen
deuterium exchange-mass spectrometry (HDX-MS) which measures differences
in deuterium uptake in the peptide backbone to determine protein-protein
interaction surfaces (24-25). We first compared high and low concentrations of
RcdA to map the dimer interface (Figure 2.18) and found these data to be
consistent with the comparison between monomeric RcdA L82E and the dimeric
wildtype RcdA that also highlights the dimerization interface (Figure 2.17A). We
then measured deuterium uptake of RcdA incubated with excess DBDTacA or PopA
to define potential interaction surfaces with these cargoes (Figure 2.17A). Each
condition is summarized in a differential deuterium uptake plot as a heat map
showing percent deuterium uptake for each peptide and regions of largest
protection (>15%) mapped onto a surface rendition of a RcdA monomer (Figure
2.17A). Individual deuterium uptake plots for selected regions of largest protection
are provided in Figure 2.17B and Figure 2.19.
Based on the PDBePISA server and the 3CTW crystal structure of RcdA, the most
buried residues in the dimer interface lie between residues 34-45 and 71-101. We
validated this in solution with our HDX-MS data which highlights residues 26-44
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and 80-97 as being most protected in the wildtype dimer (Figure 2.17A). This result
further confirms how the L82E mutation disrupts the dimer interface to generate a
monomeric variant. Consistent with our biochemical results in Figure 3,

DBDTacA

also binds the region of the dimer interface containing the L82 residue with most
protection at residues 79-101 supporting our observation that RcdA L82E fails to
deliver TacA for degradation. Interestingly, PopA also binds the dimer interface,
but principally protects residues 26-70, with the L82 containing region of RcdA
showing no substantial protection. We conclude that consistent with our
biochemical data, TacA and PopA both bind the RcdA homodimer interface to
disrupt dimerization, but they bind at different regions of this interface.
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Figure 2.17: The Dimerization Interface is Protected in the Presence of
Cargo
A) Differential uptake heatmap plots of 5μM RcdA compared with 5μM RcdA
L82E (dimerization), 600nM RcdA incubated with 20μM DBDTacA (TacA), or
600nM RcdA incubated with 20μM PopA (PopA). Regions of 15% or greater
protection are highlighted in blue on a surface rendition of the RcdA
monomer structure (PDB ID: 3CTW). B) Deuterium uptake plots of selected
peptides. Data is plotted as the mean of three replicates with the standard
deviation plotted as error bars. See chapter 2 appendix for more peptides
in the HDX datasets.

62

Figure 2.18: Mapping of The Solution Dimer Interface
Differential uptake heatmap plot of 20μM versus 600nM RcdA to illustration
dimerization interface. Given KD determined in Figure 2.5, 20 uM would be
primarily dimer while 600 nM would be primarily monomer.
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Figure 2.19: Additional Protected HDX Peptides, Related to Figure 2.17
Individual deuterium uptake plots for regions displaying >15% protection in the
RcdA-L82E, RcdA-DBDTacA, and RcdA-PopA HDX datasets. Quantification of
three independent experimental replicates is shown with the mean and standard
deviation plotted as error bars.

2.9 Mutations in the PopA interaction region highlight differences in cargo
binding
Our HDX-MS data highlights two regions in RcdA as protected upon PopA binding,
one of which includes a cluster of highly conserved basic residues (R49, K53, R57)
(Figure 2.20). We had previously identified these residues by modeling a peptide
of TacA onto the RcdA crystal structure (Appendix A.9). We mutated these
residues to glutamic acid to generate a variant that we refer to as RcdA 3E for
brevity (Plasmid made by Madeleine Sutherland), (Figure 2.21). Based on our
biochemical studies (Figure 3) we predict that both TacA and SpbR bind similar
regions of RcdA, including L82, that are distinct from the regions preferred by PopA
(Figure 4). Consistent with this hypothesis, while the RcdA 3E fails to bind PopA
based on SEC-MALS, it forms a complex and coelutes with SpbR with a measured
mass consistent with the native complex and a dimer of mass consistent with
wildtype RcdA (Figure 2.22). Given the failure to bind PopA, we were not surprised
to find that RcdA 3E was unable to deliver CtrA for degradation (Figure 2.23).
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Consistent with the preserved binding to SpbR and TacA, RcdA 3E was active for
their degradation, although not to fully wildtype activity (Figure 2.23), which we
suggest may be due to folding defects of the purified protein. Overall, these data
suggest that while the homodimer interface of RcdA is generally responsible for
cargo binding, PopA and SpbR/TacA rely on different aspects of this interface for
effective binding.
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Figure 2.20: RcdA Sequence Alignment Reveals Conserved Residues
Sequence alignment of RcdA in other alpha-proteobacteria (WebLogo, Berkeley).
The upper panel highlights in red the residues (R49, K53, R57) mutated to
glutamic acid to general RcdA 3E. The lower panel highlights in red the L82
residue mutated to glutamic acid to make RcdA L82E.
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Figure 2.21: Illustration of the RcdA 3E Mutant
Illustration of region of RcdA protected upon PopA incubation (in blue). In orange
are the 3 residues (R49, K53, R57) mutated to glutamic acids in RcdA 3E. These
mutations were not involved in interactions in the dimer interface and we
changed these amino acids solely based on charge.
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Figure 2.22: The RcdA 3E Mutant is Selective for Cargo Binding

A) Representative SEC-MALS traces for the PopA or SpbR mixtures with
RcdA 3E (red). The complex of native RcdA and cargo (black) and the
cargo alone (blue) is shown for comparison. The colored regions under
each peak represent the collected light scattering data as a distribution of
molecular weights over the width of the chromatography peak. Numbers
represent the calculated molecular weight from the scattering data. B)
SEC-MALS traces of RcdA 3E. 25μM RcdA 3E was injected over the
column. C) Chromatograms of all the SEC-MALS data collected in Figure
2.21A. Hand fractionation windows are shown above the graph. The
concentrations used were the same as the concentrations used in Figure
2.22A. D) SDS-PAGE gels of collected fractions of complexes shown in
Figure 3. Loaded fractions are numbered above each gel well, with the
first lane showing the input sample before SEC analysis.
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Figure 2.23: The RcdA 3E Variant is Selective for Cargo Delivery

A) In vitro fluorescence degradation assay of GFP-CtrARD+15 in the
presence of RcdA or RcdA 3E. Fluorescence traces are the average of
three independent replicates with error bars showing standard deviation.
The +RcdA control is the same control that was used in Figure 3C and is
shown here for comparison to RcdA 3E. B) In vitro gel-based degradation
assay of SpbR or TacA in the presence of RcdA or RcdA 3E.
Quantification of three independent replicates is shown below.

71

2.10 Defects in cargo binding affect target degradation in vivo
We finally investigated the in vivo consequences of altering RcdA-cargo
interactions. Previous in vivo work had shown that altering parts of the RcdA
interface did not dramatically affect CtrA delivery during the cell cycle (Taylor et
al., 2009). However, our specific mutations had not been tested for defects in vivo.
During the cell cycle of Caulobacter crescentus, the transition from G1 to S phase
is accompanied by a morphological change from a motile swarmer cell to a sessile
stalked cell facilitated by degradation of RcdA-dependent substrates. Because of
this transition, defects in cell-cycle are often accompanied by changes in
morphological features. We generated strains that express RcdA, RcdA L82E or
RcdA 3E at the xylX locus in ΔrcdA strains, which allows for titration of RcdA using
the inducer xylose. ΔrcdA strains have longer stalks and reduced growth in low
percentage agar, indicative of defects in cell-cycle stages and development as
stalk growth (McGrath et al., 2006, Joshi et al., 2015). At low levels of inducer,
RcdA variant levels driven by the xylX promoter were similar to that of the wildtype
control (Figure 2.24), and in these conditions, stalk length was compromised in
both RcdA L82E and 3E backgrounds (Figure 2.24), while growth in low
percentage agar was more affected in the RcdA 3E mutant (Figure 2.25).
Curiously, under high induction, where RcdA levels are well above normal, stalk
length was reduced to less than wildtype for all the alleles tested (included wildtype
RcdA) (Figure 2.25).
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These data suggest that the different substrates stabilized by the different RcdA
variants may drive defects in stalk length and agar growth separately. Consistent
with this and our in vitro results, in vivo degradation assays showed that strains
expressing RcdA L82E are deficient in SpbR degradation (Figure 2.26), while
strains expressing RcdA 3E failed to degrade CtrA during either asynchronous
growth (Figure 2.26) or during cell cycle progression (Figure 2.26).

73

Figure 2.24: Expression of the L82E and 3E Variants causes Stalk
Formation Defects

A) Western blot of steady state levels of integration strains expressing RcdA,
L82E or 3E from the xylose locus at low induction (0.002% xylose).
Quantifications are normalized to wildtype levels. B) Stalk length
quantification and images of cells expressing RcdA, RcdA L82E or RcdA 3E
from the xylose locus. Cells grown to exponential phase in media containing
0.2% (hi: high inducer), 0.002% xylose (lo: low inducer) or 0.2% glucose
(repressed). A one-tailed, unpaired t-test with α=0.05 was used to compare
stalk lengths from indicated strains.
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Figure 2.25: The RcdA 3E Variant has Motility Defects
A) Motility agar assay of each integration strain in PYE + low inducer (lo) or
glucose repressor (-) agar plates with wildtype RcdA, RcdA(L82E) or
RcdA(3E) in each spot. Images have the same absolute perimeter size. B)
Quantifications of 3 biological replicates of the motility assays in low
induction (+xylose) and no induction (+glucose) showing that cells
expressing only RcdA3E are deficient in growth in low percentage agar
media.
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Figure 2.26: The RcdA L82E and 3E Variants are Selective for Cargo
Delivery In Vivo
A) Chloramphenicol shutoff assays monitoring the degradation of SpbR and CtrA
in cells expressing wildtype RcdA or RcdA L82E. B) Synchronized cell growth of
each integration strain expressing wildtype RcdA, RcdA L82E or RcdA 3E,
showing that CtrA oscillations are lost in cells expressing RcdA 3E. Cell samples
taken at the indicated time points were probed with antibodies against CtrA and
FtsZ.
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2.11 Dimerization limits overly prolific RcdA activity
When we monitored cell-cycle progression, we noticed that CtrA levels were
slightly lower with RcdA L82E upon minimal induction of this mutant (Figure 2.26).
Interestingly, in our biochemical studies we noticed that at lower RcdA
concentrations (300 nM) the rate of PopA-mediated CtrA degradation in the
presence of RcdA L82E was faster than that found with wildtype RcdA (Figure
2.27).

When we generated enzyme-substrate reaction curves under these

conditions and fit to Michelis-Menten kinetics, we found that RcdA L82E was 2-fold
more active for PopA mediated CtrA degradation at limiting concentrations of
protease and adaptor (Figure 2.27). Since the RcdA dimer interface is also used
to bind cargo (such as PopA), this observation is most consistent with a model
where dimerization normally limits the specific activity of RcdA for cargo delivery.
We further explored this dimerization driven limit on RcdA activity in normal
physiology by constructing merodiploid strains that expressed either wildtype
RcdA or RcdA L82E from the native rcdA promoter. We found that steady state
levels of CtrA are lower and degraded faster in the RcdA L82E strain than in the
wildtype strain (Figure 2.28). During synchronized growth, CtrA is lost more rapidly
during the G1 to S transition, and re-accumulation of CtrA in predivisional cells is
reduced (Figure 6F; SI Appendix Fig. S8G). Finally, to determine the overall
fitness cost of this mutation, we used a competition assay and found that strains
expressing only RcdA L82E are at a fitness disadvantage compared to wildtype
(Figure 6G). Taken together with our biochemical results, these data suggest that
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dimerization limits RcdA activity and bypassing this restriction results in persistent
degradation of substrates such as CtrA.

Figure 2.27: The RcdA L82E Facilitates Faster Degradation of CtrA at Lower
Concentrations of RcdA
A) Normalized fluorescence degradation curves of GFP-CtrA in the presence of
different concentrations of RcdA and RcdA L82E. 500nM PopA, μM cyclic diGMP, 300nM RcdA or L82E, 0. μM ClpX, and 0.2μM ClpP and μMof GFP-CtrA
was used in this experiment. B) Initial rates of GFP-CtrA degradation as a
function of adaptor. 500nM PopA, μM CdG, 300nM RcdA or L82E, 0. μM ClpX,
and 0.2μM ClpP and varying concentrations of GFP-CtrA reporter were used in
these experiments (n=3). Fits are to the Michaelis-Menten equation.
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Figure 2.28: The RcdA L82E Variant Reduces Cell Fitness and Delivers CtrA
Faster In Vivo
A) Normalized CtrA steady levels in asynchronous cultures and their degradation
during shutoff. Quantifications are the averages of three biological replicates. B)
Representative westerns of shutoff experiments for merodiploid strains
expressing RcdA or RcdA L82E as the sole copy of RcdA under the control of the
PrcdA promoter. C) Quantification of replicate shutoff experiments. D) Fitness
competition assay between wildtype and PrcdA::RcdA or PrcdA::RcdA L82E. For all
data except the asynchronous shutoff, which were duplicate experiments,
average and standard deviation of three independent replicates is shown. E)
Representative westerns of synchronized cell growth of merodiploid strains
expressing either RcdA or RcdA L82E as the sole copy of rcdA under the control
of the PrcdA promoter. Quantification of replicate experiments are shown in Figure
6. F) Quantification of replicate shutoff experiments.
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2.12 Discussion
Adaptor mediated degradation is critical for bacteria. Our results demonstrate a
surprising feature of the cell cycle adaptor system in Caulobacter, where binding
of a cargo to the RcdA adaptor competes with homodimerization. This competition
results in stabilization of RcdA, protecting it from self-degradation by ClpXP, while
providing a relatively broad binding surface for cargo binding. We note that the
cellular concentration of RcdA estimated by ribosome profiling is 6 µM and SpbR,
PopA and TacA are between 2-4 µM each (Aretakis et al., 2019). This implies that
total cargo concentration is likely in excess of RcdA, driving the RcdA equilibrium
towards the monomer form and protecting RcdA from degradation until target
substrates are delivered by RcdA. Our binding data is consistent with the model
that different classes of cargo can interact with specific regions of this surface, with
our direct measurement by HDX-MS and our mutation data showing that we can
selectively influence particular substrate binding and degradation (Figure 2.29).
Interestingly, CpdR and RcdA are conserved throughout α-proteobacteria, while
PopA is only present in Caulobacter and closely related bacteria (Brilli et al., 2010,
Ozaki et al., 2014). The region mutated in our RcdA 3E variant may represent the
binding interface for currently unknown adaptors that fulfill the role for PopA in
other species where CtrA is degraded such as Sinorhizobium meliloti, (Pini et al.,
2015). Recent structures show that the E3 ubiquitin ligase adaptor Skp1 buries its
F-box interaction site upon dimerization (Kim et al., 2020), illustrating that masking
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of cargo binding sites by self-interactions is more generally found in biological
systems.
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Figure 2.29: Model of RcdA binding and delivery mechanism
Highlighted structure illustrating the different interactions sites of RcdA. In gold is
the dimer interface. In purple is the site involved in the SpbR and TacA interaction,
which includes the L82 residue. In ruby is the site involved in the PopA interaction,
which includes residues R49, K53, R57. Cartoon model of how the oligomerization
state of RcdA affects its activity and self-degradation. When not bound to cargo,
RcdA is dimeric and delivered to a CpdR-bound ClpXP for degradation. Cargo
binding at different interaction sites by different cargo (SpbR/TacA or PopA)
causes dissociation of the RcdA dimer and masks RcdA from its own degradation.

84

Because protease adaptors catalyze the irreversible destruction of targets, we also
considered how dimerization of RcdA could regulate adaptor activity. Our results
support two mechanisms for the role of dimerization in restricting adaptor activity:
First, because the RcdA homodimer is degraded robustly, overlapping the dimer
interface and cargo binding site adjusts RcdA levels tuned to substrate availability.
Our results show that RcdA monomers are not degraded and that binding to cargo
results in loss of RcdA dimerization. Once the substrates are degraded, RcdA
homodimers would form more readily and be destroyed. Similarly, RcdA would
never be fully eliminated as once levels drop below the dimerization constant, the
shift to the monomeric species would stabilize the adaptor.
Second, masking substrate interaction surfaces by dimerization appears to limit
degradation of substrates directly as seen with accelerated PopA-mediated CtrA
proteolysis in the presence of the monomeric RcdA variant (Figure 2.28).
Essentially, the partner monomer of a homodimer acts as an inhibitor of cargo
binding resulting in reduced degradation of substrates. Our data show that there
are physiological consequences to the loss of this limitation as cells expressing
only monomeric RcdA have lower levels and faster degradation of the essential
transcription factor CtrA, resulting in reduced fitness. We note that other protease
systems show similar constraints, for example, the N-domain of the Lon protease
interacts both with itself and some substrates (30).
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Not all dimeric adaptors share this competitive mechanism. For example, the
SspB adaptor delivers proteins marked by the ssrA-tagging system to the ClpXP
protease (Levchenko et al., 2000, Gottesman et al., 1998, McGinness et al.,
2007). Unlike RcdA, SspB binds substrates at sites far away from the dimer
interface (Chien at al., 2007) and SspB delivery is optimal when two molecules of
substrates are bound per SspB dimer (McGinness et al., 2007, Bolon et al.,
2004). Therefore, SspB activity would not be limited by competition from dimer
formation. We reason that because ssrA-tagged proteins naturally arise from
failed translation (Levchenko et al., 2003, Keiler et al., 2015), these targets
should always be destroyed, therefore prolific SspB activity would not be toxic.
By contrast, degradation of RcdA dependent substrates occurs only at a specific
stage of the cell-cycle (McGrath et al., 2006, Joshi et al., 2015) and additional
controls to limit this adaptor activity, such as the mechanism we describe here,
would be beneficial. We speculate that other adaptors that deliver substrates in
such a highly timed manner may also be subject to similar regulation.

86

2.13 Materials and Experimental Procedures
Protein Expression and Purification. BL21(DE3) pLYS or X90 cells with
expression plasmids for different proteins were grown at 37°C to an OD600 of 0.40.6, then induced with 0.4mM IPTG for 3-4 h. Induced cells were then centrifuged
at 7,000g for 10 minutes and resuspended in buffer containing 50mM Tris pH 8.0,
300mM NaCl,

0mM imidazole,

0% glycerol, 5mM β-mercaptoethanol and

100mM PMSF and frozen at -80°C until further use. Cells were lysed using a
Microfluidizer system (Microfluidics, Newton, MA). The clarified lysate was bound
over a Ni-NTA column for affinity purification. H6SUMO-tagged proteins were
cleaved by Ulp1-his protease (36). Proteins were then purified using size exclusion
and anion-exchange chromatography using Sephacryl 200 16/60 and MonoQ 5/50
columns. ClpX and ClpP were purified as outlined in (9). Detailed purification
protocols are available upon request. For all in vitro experiments RcdA
concentrations are stated in terms of monomeric equivalents unless otherwise
noted.
Cloning and Molecular Biology. RcdA variants were cloned using around-thehorn site-directed mutagenesis by amplifying the desired plasmid using
pET23SUMO-RcdA as a template. To generate the ΔrcdAXylX::Pxyl integration
strains, the pXGFPN-1 plasmid (37) was used a template to generate a vector with
the RcdA, RcdA(L82E) and RcdA(3E) coding sequences under the xylose
promoter. The coding sequence of RcdA, RcdA(L82E) or RcdA(3E) was amplified
with complementary overlaps to this vector and the final construct was generated
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using Gibson assembly method (38). Competent ΔrcdA Caulobacter cells were
transformed with pXGFPN-1-RcdA, RcdA(L82E) or RcdA(3E) containing plasmids
and selected on 30 μg/mL spectinomycin/streptomycin plates. To generate RcdA
or RcdA L82E merodiploid strains, we performed around the horn mutagenesis on
the wildtype RcdA pENTR gateway cloning vector (EPC 721) using the same
primers used to make the original L82E mutation. We transformed this plasmid into
competent wildtype cells and selected on 50 µg/ml kanamycin containing PYE
plates. We confirmed insertion of the L82E coding sequence by Sanger
sequencing.
In Vivo Protein Stability and Synchrony Assays. Wildtype or Caulobacter cells
expressing different constructs from a xylose inducible promoter or from the native
rcdA locus were grown in PYE media with appropriate antibiotic and xylose when
required as outlined in the figure legends. Cells were grown to an OD 600 of ~0.4
with addition of 0.2-0.002% xylose or 0.2% glucose (when noted). Protein
synthesis was blocked by addition of 30 μg/mL chloramphenicol and aliquots were
taken at the timepoints indicated in the figures. For synchrony experiments, an
asynchronous population of cells was grown to an OD600 of ~0.4 in PYE. Swarmer
cells were harvested and isolated using Percoll density gradient centrifugation,
then released into fresh PYE media containing 0.002% xylose (when needed) for
progression through the cell cycle.
Microscopy. Phase contrast microscopy was performed on glass slides layered
with a 1% agarose pad. A Zeiss Scope A.1 microscope (Zeiss, Germany) equipped
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with 00X ( x25 oil ∞/0. 7) objective and 60 N-C ″ 00x camera was used.
Images were analyzed with BacStalk (Drescher Lab, Max Planck Institute)
software. Stalk distributions were compared using a one-tailed unpaired t-test with
α = 0.05 (GraphPad Prism).
Motility Assays. Motility assays were performed as described previously (36).
Briefly, 0.3% agar plates containing varying concentrations of xylose and glucose
were inoculated with three independent colonies of each strain for 3 days at 30°C.
Colony sizes were determined using ImageJ (NIH). Quantifications were
completed using ImageJ and plotted in GraphPad Prism.
In Vivo Growth Competition Assay. Overnight cultures of a strain constitutively
expressing the fluorescent reporter Venus (CPC798) were mixed with Wildtype,
PrcdA::RcdA, PrcdA::RcdA L82E at a 1:1 ratio. Mixed strains were then diluted
1:15000 into fresh media and allowed to outgrow for 24 hours. The initial 1:1
mixture of cells was verified by phase contrast and fluorescence microscopy.
Quantification of >100 cells was performed for 3 biological replicates. All final ratios
were normalized to their starting ratios prior to dilution. Statistical analysis was
performed using an unpaired t-test in GraphPad Prism.
Western Blot Analysis. Aliquots withdrawn at indicated time points were spun
down, resuspended in 2X SDS sample buffer, boiled at 95 °C for 10 min and then
centrifuged. After centrifugation, 10 µl of clarified supernatant was loaded onto
SDS-PAGE gels. Proteins were then transferred onto a nitrocellulose membrane
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at 20V for 1 hour and probed for monoclonal rabbit anti-RcdA (1:5000), monoclonal
rabbit anti-ClpP (1:5000), polyclonal rabbit anti-SpbR (1:5000), rabbit anti-FtsZ
(1:5000), or rabbit anti-CtrA (1:5000). Following overnight primary probing at 4°C,
the membranes were washed 3 times with TBST. Proteins were then visualized
using IRdye-labeled goat anti-rabbit antibody (LI-COR Biosciences) at 1:10000
dilution and an Odyssey Scanning system (LI-COR)
Fluorescence Polarization and Maleimide Labeling. Purified RcdA or RcdA
mutants were labeled with Fluorescin-5-Maleimide (Thermo ScientificTM). Purified
protein at ~8-10 mg/mL was buffer exchanged into labeling buffer (50 mM Tris pH
7.0, 150mM NaCL, 2mM TCEP). Fluorescin-5-Maleimide was dissolved in DSMO
and added to protein at a 20-fold molar excess to cysteine. Labeling reactions were
completed at 4°C overnight. Free dye was removed using a PD-MidiTrap column
(GE Healthcare) and Amicon Ultra-15 Centrifugal Filter Units in a buffer containing
20mM HEPES pH 8.5, 100mM KCL, 10mM MgCl2 and 0.05% Tween.
Confirmation of protein labeling was verified using a Typhoon imaging system (GE
Healthcare). The labeled protein was aliquoted, and flash frozen at -80°C.
Fluorescence polarization binding experiments were performed with 100 nM
labeled Rcda or RcdA L82E and varying concentrations of cargo. The binding
reaction was incubated at 25°C for 1hr to reach equilibrium. Polarization
measurements were read from 40uL of these mixtures using opaque black 384well plates using a SpectraMax M5 plate reader (Molecular Devices) with excitation
and emission wavelengths set at 460 and 540, respectively. Equilibrium binding
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constants were calculated by fitting the polarization data using GraphPad Prism to
a one site, total and nonspecific binding equation P = Pmax*[X]/([X] + K d) + NS*[X]
+ Background, where Pmax is the maximum specific binding value, P is the
polarization value, NS is the slope of linear nonspecific binding constrained to be
greater than 0, and the background is the polarization value when [X] is 0. Error
bars are calculated from the standard deviation between replicates of experiments.
All RcdA concentrations are in terms of monomeric equivalents unless otherwise
noted.
Chemical Crosslinking. For crosslinking experiments, 100 μM RcdA or L82E was
incubated with increasing concentrations of glutaraldehyde as annotated.
Crosslinking was performed in 20 mM HEPES buffer, pH 7.5 with 100mM KCL and
quenched after 2 hours of incubation at room temperature with 1M Tris pH 8. The
resulting mix was then desalted into the same HEPES buffer used for
Fluorescence Polarization experiments.
Isothermal Titration Calorimetry (ITC). ITC experiments were completed using
a Malvern-autoiTC200 automated system (Malvern). Measurements were taken at
25°C. The reference cell was filled with 20 mM HEPES pH 8.5, 100mM KCL and
10% glycerol. This buffer was used for all ITC experiments and for dialysis of each
protein into the same buffer prior to the experiment. The sample cell was loaded
with 400μL of 40μM pbR and the stirring syringe was loaded with 20μL of 400μM
RcdA. 19 injections of RcdA into SpbR were used to build the binding isotherm.
Data analysis was performed with MicroCal (ORIGIN) and fitted to a single set of
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identical sites equation Kd = (Θ)/(( -Θ)*[X]), where Θ is the fraction of sites
occupied by ligand X and [X] is the concentration of ligand X. For dimer
dissociation, the sample cell was loaded with 400μL of the buffer described above
and the stirring syringe was loaded with 20μL of 400μM RcdA. Dissociation data
was fit to the dimer dissociation model in ORIGIN (P2 -> 2P)
Size-Exclusion Chromatography with Multi-Angle Light Scattering. Each
protein complex was allowed to bind at room temperature for 45 minutes. The
complexes were then injected onto a T Kgel™ G3000

EC column equilibrated

in 20mM HEPES buffer, pH 7.0 with 100mM Potassium Chloride and 10% glycerol
(Tosoh Biosciences) at room temperature. The SEC column was coupled to an 18angle light scattering detector (DAWN HELEOS-II) and a refractive index detector
(Optilab T-rEX) (Wyatt Technology). Data was collected every second and the flow
rate was set to 0.5 mL/min. Data analysis was carried out using the program
ASTRA (Wyatt Technology). Monomeric bovine serum albumin (BSA; Sigma) was
used for calibration of the light scattering detectors and general data quality
control. Measurements were taken at 25°C. The light scattering data was collected
across a window containing the entire chromatographic peak for a full distribution
of molecular weights, shown underneath each chromatogram. The monomeric
equivalent concentrations used in the SEC-MALS experiments are as follows
unless otherwise noted in the figure legends: 25μM RcdA, 25μM RcdA L82E, 25μM
RcdA 3E, 50μM PopA, 50μM pbR, 5μM His-TacA. We used 50μM of RcdA and
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SpbR for Figure 1 and Figure 3. The concentrations we used in our coelutions
studies were the same concentrations used in our SEC-MALS studies.
Microscale Thermophoresis (MST). The MST experiments were performed
using a Monolith NT.115 instrument (NanoTemper). Fluorescin-5-Maleimide
labeled RcdA was incubated with increasing concentrations of unlabeled RcdA in
the same buffer used in the polarization experiments. The measurements were
performed at 20% MST power with 40% LED Power and with 3 s laser on time and
25 s off time. The Kd values were calculated using MO Affinity Analysis software
(NanoTemper) and fit to the nonlinear equation Fnorm = [unbound + (boundunbound) / 2 * (FluoConc + c + Kd – Sqrt((FluoConc + c + Kd)^2 – 4*FluoConc*c)],
where unbound and bound are the thermophoresis values of the unbound and
bound states, FluoConc is the fixed concentration of the fluorophore, Fnorm is the
normalized fluorescence, and c is the concentration of the unlabeled protein.
Hydrogen-Deuterium Exchange Mass Spectrometry. Hydrogen-deuterium
exchange was measured on a Synapt G2Si high definition mass spectrometer
(Waters). Deuterium exchange and quenching steps were performed using an
automated HDX robotics platform (Waters). Samples were diluted 1:16 in D2Ocontaining buffer containing 0.1 mM K2HPO4 to final concentrations as specified in
the figure legends. Deuterium exchange was allowed to take place for 0, 1, 10 and
60 minutes at 25°C, with staggered starts for each dilution reaction. After all
reactions were completed, aliquots were removed and diluted 1:2 into cold quench
buffer at 4°C (water with 4M Guanidine Hydrochloride at pH 2.5) and
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subsequentially run over an immobilized Water ENZYMATE immobilized pepsin
column (ID: 2.1 length: 30mm) at a flow rate of 0.15mL/min at high pressure
(~11000 psi) for peptide digestion. Prior to HDX analysis, the quality of each
sample was assessed using SDS-PAGE and size-exclusion chromatography.
Three independently prepared experimental replicates and labeling reactions were
performed for each condition and averaged in the peptide uptake plots. Blank runs
were run in between each analysis to avoid peptide carry-over. Continuous lockmass correction was performed using leu-enkephalin compound. Timepoints and
analysis were randomized to ensure no biasing of results and to ensure variation.
Peptides were ionized and separated by electrospray ionization for analysis in
MSE mode at a mass resolution of 50-2000 m/z range. Identification of peptides
and analysis of the uptake plots and charge states for each peptide were
completed in Protein Lynx Global Server (PLGS) and the software DynamX
(Waters). Differential uptake heatmaps and uptake plots were plotted and created
in Adobe Illustrator and in GraphPad Prism. Protections of greater than 15% are
shown on the surface renditions of the RcdA structure (PDB 3CTW) using PyMol
(Schrodinger Software)
In vitro Degradation Assays. Degradation of proteins was monitored using SDSPAGE gels as described previously (21). The concentrations of different proteins
used in degradation reactions are indicated in the figure legends. Degradation of
GFP-CtrARD+15 was monitored with the loss of fluorescence over time as
described previously (18). The concentrations of each protein used in the reactions
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were as follows unless otherwise noted: 3μM RcdA, 3μM RcdA(L82E), 3μM
RcdA(3E), 2μM CpdR, 0.2μM ClpX6, 0.4μM ClpP14,

μM GFP-DBDTacA, 4μM

pbR, 4μM TacA, 2μM GFP-CtrARD+15, 5mM ATP. For GFP-CtrARD+15
experiments in Figure 6C, we used 1uM GFP-CtrARD+ 5, 500nM PopA,

μM

CdG, 300nM RcdA or L82E, 0. μM ClpX, and 0.2μM ClpP. GFP-CtrARD+15 and
GFP-DBDTacA curves were fit to a modified hyperbolic equation with the form of: Y
= ((Vmax * [RcdA]) / (Kact + [RcdA])) + A, where A is a baseline constant, or to the
Michaelis-Menten equation using GraphPad Prism.
Sedimentation Velocity Analytical Ultracentrifugation. Sedimentation Velocity
experiments were completed using a Beckman ProteomeLab XL-1 Analytical
Ultracentrifuge (Beckman). Samples were diluted into 20 mM HEPES pH 8.5,
100mM KCl, 10% glycerol at the concentrations indicated in the figure legends.
The samples were spun at 55,000 g overnight at 25°C. The ρ and v values used
for data fitting were determined using SEDNTERP and the amino acid sequence
for each protein. The sedimentation velocity data was directly fit to the c(s)
distribution method using the program SEDFIT and using the first 100 velocity
scans for each condition. The resulting distributions from each experiment were
then plotted in GraphPad Prism. The final concentrations used were the same
concentrations used in the SEC-MALS experiments.
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Bacterial Strains Used in This Study:
Organism
C.crescentus

Name
CB15N

CPC452
CPC963
CPC964
CPC965
E. coli

TOP10
BL21(DE3)
pLysS
X90 T7
EPC100
EPC112

EPC162

BPC180
BPC238
EPC196

EPC677
EPC811

EPC812

Description
synchronizable
derivative of wildtype CB15
ΔrcdA (hygR)
ΔrcdAXylX::PxylRcdA
ΔrcdAXylX::PxylL82E
ΔrcdAXylX::Pxyl3E
Cloning strain
recombinant
protein expression
recombinant
protein expression
dh5alpha pQE70his-ClpP
BL21DE3 pLysS
pET23 Ulp1his
protease
BL21DE3 375
eGFP-His6CtrARD+15
Top10 pXMCS-2
BL21DE3 plysS
pET23 ClpX
BL21DE3 plysS
pET23b
His6Sumo-CpdR
BL21DE3 plysS
375 His6-TacA
BL21DE3 plysS
pET23b
His6SumoTacADBD (437488)
BL21DE3 plysS
pET23b
His6Sumo-SpbR
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Source
(Evinger and
Agabian, 1977)
(Mcgrath et al.,
2006)
This study
This study
This study
Invitrogen
Invitrogen
From Bob Sauer
(Chien et al.,
2007)
This study

(Smith et al.,
2014)
This study
(Chien et al.,
2007)
(Lau et al., 2015)

(Joshi et al.,
2015)
(Joshi et al.,
2015)

(Joshi et al.,
2015)

EPC960

EPC967

EPC970

EPC1000
EPC1037

EPC1129

EPC1517

BL21DE3 plysS
pET23b
His6SumoSpbRDD
BL21DE3 plysS
pET23b
His6SumoRcdAΔC
BL21DE3 plysS
pET23b
His6Sumo-RcdA
TOP10 pET23b
His6Sumo-RcdA
BL21DE3 plysS
pET23b
His6Sumo-PopA
BL21DE3 plysS
pET23b
His6Sumo-RcdA
3E
BL21DE3 plysS
pET23b
His6Sumo-RcdA
L82E
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(Joshi et al.,
2015)

(Joshi et al.,
2015)

(Joshi et al.,
2015)
(Joshi et al.,
2015)
(Joshi et al.,
2015)
This study

This study
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3.1 Abstract
Regulated protein degradation is aided by specificity factors called adaptor
proteins that alter the substrate selection of their respective proteases. In
Caulobacter crescentus, the PopA adaptor, along with two other adaptors,
controls the regulated degradation of the replication inhibitor, CtrA. In doing so,
PopA must make interactions with the RcdA adaptor and the small molecule,
cyclic-di-GMP, to deliver CtrA to ClpXP during the cell cycle. However, how PopA
coordinates interactions with RcdA and CtrA to perform its delivery function is
poorly understood. Here, we provide mechanistic details into the determinants of
PopA responsible for RcdA, CtrA and cdG interactions using statistically filtered
Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) experiments. We
map the surfaces involved in the binary PopA-RcdA and PopA-cdG complex and
the surfaces involved in the PopA-RcdA-CtrA ternary complex and show that this
ternary complex forms in vitro. We show that, in solution, PopA must facilitate
conformational changes throughout the protein through cdG binding to facilitate
its functional state while degrading CtrA. Our findings suggest that RcdA and
CtrA share nonoverlapping surfaces on PopA and determine that PopA can
accommodate both CtrA and RcdA interactions as a monomer. This work
provides mechanistic insight into PopA-dependent delivery that will likely extend
to other bacteria that use the adaptor-CtrA degradation pathway.
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3.2 Introduction
Regulated protein degradation controls many key aspects of physiology and is
essential for proper homeostasis. In Bacteria, AAA+ (ATPases with Associated
Activities) proteases degrade misfolded and native substrates to maintain proper
homeostasis and regulate cell-cycle progression (Mahmoud et al., 2018). The
Clp family of proteases, which include the protease ClpXP, are essential for
degrading proteins necessary for maintaining normal cell physiology in bacteria
and eukaryotic organelles (Truscott et al., 2011, Olivares et al., 2018). AAA+
protease work by using two functional modules: an oligomeric unfoldase which
recognizes a short degradation motif and consequentially unfolds proteins into
the peptidase module, which non-specifically cleaves proteins into smaller
peptide fragments (Sauer and Baker, 2011).
To properly regulate the specificity of their targets, bacterial proteases use
accessory factors, or adaptors, to control the specificity of the protease
(Kuhlmann et al., 2017). Adaptors can either act as scaffolds by increasing the
local concentration of substrate through tethering or by priming the protease by
binding to the unfoldase module and promoting recognition of substrates. In the
alpha-proteobacterium Caulobacter crescentus, a hierarchy of adaptors controls
protein degradation during cell-cycle progression and development (Joshi et al.,
2015). In this proteolytic pathway, the CpdR binds to ClpX, activating it and
recruiting a specific set of substrates (Iniesta et al., 2006, Lau et al., 2015). The
second adaptor, RcdA, binds to CpdR by its c-terminal tail and delivers its own
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set of substrates through direct interactions with its cargo (McGrath et al., 2006,
Joshi et al., 2015, Kuhlmann et al., 2021). Finally, the third adaptor, PopA,
interacts with RcdA and the small molecule cyclic-di-GMP (cdG) to deliver the
replication inhibitor and master regulator of the Caulobacter cell cycle, CtrA
(Quon et al., 1996, Duerig et al., 2009, Ozaki et al., 2014). PopA was discovered
to be a gene duplication product of the diguanylate cyclase enzyme PleD through
functional characterization of Caulobacter crescentus proteins involved in cdG
turnover (Duerig et al., 2009). While PopA can bind cdG specifically, it lacks
diguanylate cyclase (DGC) activity, suggesting that PopA evolved from PleD to
serve a different function (Duerig et al., 2009). Through bioinformatic
comparisons with PleD, it was found through homology modeling that PopA
shares a common response regulator fold like PleD and other DGC enzymes
found in other bacteria, such as WspR (De et al., 2009) and DgcB (Meek et al.,
2019). The conserved response regulator structure uses input receiver domains,
where phosphorylation of a conserved site shifts the response regulator from an
inactive conformation to an active conformation (Gao et al., 2019). For DGC
enzymes, phosphorylation and cdG binding to the GGDEF domain gate the
catalytic behavior of the enzyme. For PleD, phosphorylation and cdG binding
allow for dimerization of the PleD enzyme necessary for catalytic activity
(Wassman et al., 2007, Chan et al., 2004). Surprisingly, despite evolving from the
PleD gene, PopA is not regulated by phosphorylation (Ozaki et al., 2014) but
PopA’s CtrA delivery activity is gated by cdG binding (Ozaki et al., 20 4).
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Furthermore, PopA can interact with RcdA without its GGDEF domain,
suggesting a role for its receiver domains in facilitating protein-protein
interactions (Ozaki et al., 2014). It has been suggested that PopA can forms
dimers in the presence of cdG in vivo (Wang et al., 2021). While both PopA and
RcdA are necessary for delivery of CtrA during the Caulobacter cell cycle, the
mechanism by which PopA interacts with RcdA and CtrA to promote delivery
remains unclear.
Here, we provide detailed characterization of the PopA-RcdA-CtrA ternary
complex and the surfaces on PopA responsible for each binary interaction using
hydrogen-deuterium exchange and statistical filtering of each dataset. We found
that different peptides were protected across each dataset in the ternary complex
versus each binary complex and provide proposed interaction surfaces arising
from our HDX-MS data. We confirm that RcdA, PopA and CtrA form a ternary
complex only in the presence of cdG. We show that, in solution, PopA must
facilitate conformational changes throughout PopA through cdG binding to
facilitate its functional state while degrading CtrA and that, surprisingly, PopA
binds CtrA as a monomer only in the presence of cdG. Our findings suggest that
RcdA and CtrA share nonoverlapping surfaces on PopA and that PopA binds
CtrA and RcdA as a monomer.
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3.3 Results
RcdA, CtrA and PopA form a Ternary Complex
We began our studies by performing interaction studies to determine if PopA can
interact with RcdA and CtrA to form a ternary complex. PopA and RcdA interact
directly without cdG, where a monomer of PopA binds a monomer of RcdA
(Duerig et al., 2009, Smith et al., 2014, Kuhlmann et al., 2021) and it is
suggested PopA can interact with CtrA only in the presence of cdG (Smith et al.,
2014). We decided to perform a nickel pulldown experiment using a 6xHis tagged
CtrA (His6-CtrA) to assay for PopA-RcdA-His6-CtrA ternary complex formation.
We replicated the results from (Smith et al., 2014) showing that PopA can only
be pulled down by CtrA in the presence of cdG (Figure 3.1A). In the presence of
RcdA, all three proteins were present in the elution fraction, suggested binding of
RcdA and His6-CtrA to PopA simultaneously (Figure 3.1B). Interestingly, cdG
does not affect RcdA’s affinity for PopA, suggesting that the binding of cdG to
PopA affects CtrA interactions independently of RcdA (Figure 3.2). Because
PopA might form a dimer in presence of cdG, we asked whether there might be
another role for cdG in facilitating PopA-CtrA interactions and whether CtrA and
RcdA might share a common interaction surface on PopA.
Mapping of the RcdA-PopA Interaction Surface
We next performed Hydrogen-Deuterium Exchange Mass Spectrometry (HDXMS), which measures changes in deuterium uptake in the peptide backbone of
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proteins to map out the protein-protein interfaces of each binary complex and the
PopA-CtrA-RcdA ternary complex (Konermann et al., 2011, Chalmers et al.,
2011). We began by mapping out the surface on PopA masked by RcdA binding.
Our initial PLGS searches yielded over 4,000 peptides, making interpretation of
our data challenging. Using a statistical filtering program designed to provide
more rigorous filtering of HDX-MS data (Hageman and Weis, 2019, Lau et al.,
2020), we identified and narrowed our scope of peptides that showed the most
protection across the time course of the HDX-MS assay. Our initial HDX data
showed coverage across the entire protein, but we specifically looked for regions
that showed up as the most protected after providing a p-value cutoff filter of
0.05. Peptides spanning residues 127-169, residues 267-275, and residues 296302 showed the strongest protection on PopA in the presence of RcdA after
application of statistical filtering in the Deuteros software (Figure 3.3A). Using
Phyre2 fold prediction, we generated a homology model of PopA using the
inactivated crystal structure of PleD as a model (Chan et al., 2004). We took the
statistically filtered HDX data and mapped the protected and more exposed
regions onto the modeled structure (Figure 3.3B). The protected regions formed
a distinct surface on PopA that span through the last 4 amino acids of the 1st
receiver domain through most of the second receiver domain. Our data is
consistent with the 2nd receiver domain of PopA comprising most of the
interaction surface in the PopA-RcdA interaction. Individual peptide uptake plots
are provided to highlight peptides of significant difference in Figure 3.3C. To test
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whether the 1st receiver domain is sufficient to bind RcdA, which has been
previously suggested by BATCH, we made a 1st receiver domain truncation (1117) that lacked the second receiver domain and tested whether this domain
would be able of binding RcdA by size-exclusion chromatography coupled with
multi-angle light scattering (SEC-MALS). Consistent with the second receiver
domain being needed for RcdA-PopA interactions, we did not see any binding of
this truncation construct by SEC-MALS (Figure 3.4). Interestingly, this construct
could compete off GFP-DBDTacA degradation, a direct test of RcdA-mediated
degradation (A.14). To confirm our original HDX data and to ensure that the
interaction surface on PopA does not change for RcdA when cdG is bound, we
performed SEC-MALS with PopA incubated with RcdA and cdG and did a
pairwise state comparison in Deuteros to PopA incubated with cdG. Consistent
with our PopA-RcdA HDX results, we saw a large cluster of protected peptides
primarily in the 2nd receiver domain, supporting a model where the PopA-RcdA
interaction surface consists of the 2nd receiver domain (Figure 3.5).
Cyclic-di-GMP binding allows for PopA-CtrA interactions by
Conformational Changes in PopA
We next tested to see what surfaces were protected on PopA in the presence of
cdG, the small molecule necessary for CtrA delivery (Duerig et al., 2009). It has
been suggested that cdG helps PopA forms dimers in vivo (Wang et al., 2021),
however, there lacks strong evidence for PopA dimerization in vitro. We took into
consideration that the inactive structural model of PopA might not reflect the
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conformation of PopA in the presence of cdG, as the active conformation of PleD
when it dimerizes in the presence of cdG is different than the inactive
conformation. In the presence of cdG, we saw much of the PopA protein become
protected from deuterium uptake over the course of the assay (Figure 3.6A). We
looked for specific interfaces that could function as the dimer interface between
two copies of the modeled PopA structure based on the inactive and active
crystal structures of PleD (Wassman et al., 2007, Chan et al., 2004).
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Figure 3.1: His6-CtrA Nickel Pulldown Assay
A) SDS-Page gels of Nickel Pulldown assay of His6-CtrA alone, PopA alone
and PopA + CtrA in the presence and absence of cdG. 10µM PopA or
His6-CtrA were incubated with 50µL of pre-equilibrated Ni-NTA resin. The
resin was washed and eluted as described in the methods. B) SDS-Page
gels of Nickel Pulldown assay of His6-CtrA alone, RcdA alone and His6CtrA + RcdA, and His6-CtrA + RcdA and PopA in the presence of cdG.
10µM PopA, His6-CtrA or RcdA were incubated with 50µL of preequilibrated Ni-NTA resin. The resin was washed and eluted as described
in the methods section.
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Figure 3.2: RcdA Interacts with the Second Receiver Domain of PopA by
HDX-MS

A) Hybrid statistical Woods plot of filtered HDX peptides. Peptides from
the each timepoint are highlighted, with peptides showing lower
statistical HDX change in blue, and higher statistical HDX change in
red. Insignificantly changing peptides are in grey. Each domain of
PopA is annotated under the residue number. A significance filter of
ɑ = 0.05 was used. B) Mapped HDX changes from the Woods plot
onto a SWISS-MODEL modeled PopA structure based on the
inactivated crystal structure of PleD (PDB code: 1W25) for the 60
minute timepoint. Highlighted surfaces, peptides and regions on PopA
are shown in each depiction C) Selected peptides from the second
receiver domain that are highly protected upon RcdA binding from the
Woods plot.
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Figure 3.3: RcdA binds PopA and PopA-cdG with Similar Affinity

A) Fluorescence polarization binding curve of a fluorescently labeled RcdA
with increasing concentrations of PopA. 100nM RcdA was incubated
with up to 40uM PopA. Polarization data was fit to a single site binding
model as described in the methods. B) Fluorescence polarization
binding curve of a fluorescently labeled RcdA with increasing
concentrations of PopA. 100nM RcdA was incubated with up to 40uM
PopA and 100uM cdG.
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Figure 3.4: The First Receiver Domain is Insufficient to bind RcdA by SECMALS
SEC-MALS analysis of PopARD-1 (1-117) incubated with RcdA by SEC-MALS.
The first receiver domain is incapable of forming a higher-order complex with
RcdA, as evidenced by the lack of a peak shift in the chromatogram. Surprisingly,
The PopARD1 could compete off GFP-TacA Degradation (Appendix A.14)
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Figure 3.5: RcdA Interacts with the Second Receiver Domain of PopA when
cdG is present
Hybrid statistical Woods’s plot of filtered HDX peptides for PopA-RcdA-cdG
compared to PopA-cdG. Peptides from the 1 minute, 10 minute and 60
minute timepoints are highlighted, with peptides showing lower statistical
HDX change in blue, and higher statistical HDX change in red.
Nonsignificant changing peptides are in grey. A significance filter of ɑ =
0.05 was used. This experiment shows that the PopA-RcdA interaction
surface does not dramatically change when PopA is bound to cdG.
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Figure 3.6: CdG Binding Causes Conformational Changes in PopA

A) Hybrid statistical Woods plot of filtered HDX peptides. Peptides from the
1 minute, 10 minute and 60 minute timepoints are highlighted, with
peptides showing lower statistical HDX change in blue, and higher
statistical HDX change in red. Nonsignificant changing peptides are in
grey. B) Mapped HDX changes from the Woods plot onto a SWISSMODEL modeled PopA structure based on the inactivated crystal
structure of PleD (PDB code: 1W25) for the 60 minute timepoint.
Highlighted surfaces, peptides and residues in each patch are shown in
each graphical representation. The C-terminal patch that is highlight in
the PopA-cdG HDX data is highlighted in gold. C) Selected peptides
that are highly protected upon cdG binding from the Woods plot.
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We first checked to see if residues in the primary I site of the GGDEF domain
were protected in our dataset, as mutations in this site disrupt cdG binding and
this was a good indication that PopA and cdG were binding in our experiments.
Consistent with this data, we saw protection from deuterium in the primary I-site
spanning over R357, the residue shown to be necessary for cdG binding (Figure
3.2A, Duerig et al., 2009). Even with the most stringent statistical cutoffs (p =
0.001) selective peptides in the I-site were protected from deuterium exchange.
Next, we looked for any interfaces that might potentially form a dimer in the
active modeled structure. Work from (Ozaki et al., 2014) identified the dimer
interface forming between the rec1 and rec2 domains of PopA in this model,
which was primarily formed by a salt bridge comprised of residues R118, E125
and E129. However, mutations in these residues did not affect CtrA delivery,
which is dependent on PopA-cdG interactions (Ozaki et al., 2014). This suggests
that the rec1-rec2 dimer interface model based on the PleD crystal structure
does not contain any potential dimer interface of PopA. Consistent with this,
these residues were not protected in any timepoint throughout the HDX-MS
experiment (Figure 3.6A). There did not seem to be any interfaces formed in both
the inactive and active state modeled structure of PopA that could lend itself to a
dimer interface. At the concentrations used in our HDX experiments (5uM PopA
and 40uM cdG), we wanted to see if our HDX data could be explained by
changes in the PopA structure rather than dimerization. We tested to see if PopA
could form dimers by analytical ultracentrifugation at concentrations of PopA and
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cdG that fully stimulate CtrA degradation, which we found to be at its maximal
degradation rate at 10uM of cdG (Figure 3.7)

Figure 3.7: Activation curve of GFP-CtrA Degradation by cdG
Kactivation curve of GFP-CtrA degradation in the presence of varying
concentrations of cdG and 5uM PopA, 3uM RcdA, 3uM CpdR, 0.2uM ClpX,
0.4uM ClpP and 1X ATP Regeneration mix. Data was fit to a modified version of
the Michaelis-Menten equation to account for background degradation as noted
in the methods.
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Figure 3.8: Sedimentation Velocity-AUC of PopA in the Presence of cdG

A) Sedimentation-Velocity AUC Distribution of 25µM PopA. The distribution
statistics and fitted parameters are listed next to the graph. B)
Sedimentation-Velocity AUC Distribution of 5µM PopA in the presence of
40µM cdG. The distribution statistics and fitted parameters are listed next
to the graph.
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Consistent with this, we did not see dimerization of PopA at fully stimulatory
concentrations by AUC and no evidence of dimerization at high concentrations of
PopA alone without cdG present (Figure 3.8). Surprisingly, the frictional ratio of
PopA was 1.9, indicated an elongated conformation like that of an antibody. This
ratio did not change upon cdG addition (Figure 3.8B). Therefore, the deuterium
protection and CtrA binding in the presence of cdG is more likely explained by
conformational changes in PopA upon cdG binding to promote ctrA binding. We
wanted to see if CtrA affected the dimerization state of PopA upon binding, which
we could not do by AUC due to limitations in the absorbance optics of the
instrument. To do this, we used SEC-MALS to assess the oligomerization state
of PopA upon CtrA binding. We ran both CtrA, PopA and RcdA on SEC-MALS
with buffer that contained cdG. CtrA ran as a 27kDa monomer by SEC-MALS,
while PopA ran as a 44kDA monomer. As predicted by previous experiments, the
RcdA + PopA complex ran as a 59kDA complex (Figure 3.9A). We next ran PopA
and CtrA together and found the complex to be approximately 70kDa, close to a
predicted mass of a monomer of PopA bound to a monomer of CtrA (Figure
3.9B). We next tested to see if we could see the ternary complex being formed
when we added RcdA to a PopA-CtrA reaction. The chromatography peak that
formed did not scatter light and ran as a smear (Figure 3.9B), making it
challenging to determine the stoichiometry of the ternary complex. Combined
with the fact that the Kactivation constant for cdG-stimulated CtrA delivery is ~1.5uM
and PopA-CtrA form a 1:1 complex, we reason that cdG causes changes in the
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PopA structure upon binding to accommodate CtrA interactions. We analyzed
our HDX further to see if any specific domains or regions on PopA particularly
changed upon cdG binding. The region with the most protected peptides was
centered around residues 410-441, the end of the C-terminus of PopA (Figure
3.5B). One possible model is that proper orientation of the C-terminus of PopA is
required for CtrA binding, explaining why this region is highly protected upon cdG
binding. Taken together, our data favors a model where PopA dimerization by
cdG is not necessary for CtrA delivery but rather cdG binding is required for
priming PopA for CtrA interactions by conformational changes that provide a
more compact structure or surface that promotes CtrA binding.
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Figure 3.9: PopA and CtrA form a Monomer:Monomer Stoichiometry by
SEC-MALS

A) SEC-MALS traces of RcdA, PopA, CtrA or different pairwise
combinations of each protein in buffer not containing cdG. Each protein
was run at 50uM alone or together. The dotted lines indicate the
weight-averaged mass from the light scattering detector of each
protein or protein complex. B) SEC-MALS traces of RcdA, PopA, CtrA
or different pairwise combinations of each protein in buffer containing
0.5mM cdG that was freshly prepared. Each protein was run at 50uM
alone or together. The dotted lines indicate the weight-averaged mass
from the light scattering detector of each protein or protein complex.
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CtrA interacts at a Nonoverlapping Surface on PopA
We concluded our HDX studies by comparing the PopA-cdG bound complex to a
reaction consisting of PopA, cdG and RcdA and another reaction containing
PopA, cdG,RcdA and CtrA. Our reasoning for this was that we could only
compare the interactions of CtrA in the context of cdG and RcdA, as both are
necessary for CtrA delivery and RcdA also makes direct interactions with PopA
during this delivery process. By performing these comparisons in the same HDX
experimental run, we can compare the peptide uptake and see which regions are
protected in the presence of CtrA specifically after subtracting the contributions
from cdG and RcdA. Most of the surface that was identified in the PopA-RcdA
dataset did not change upon addition of CtrA, suggested that no further
protection of this region occurs in the presence of CtrA as was seen for the
PopARcdAcdG dataset (Figure 3.10A). However, there was some residues and
patches that were shared with the RcdA dataset, such as regions 155-162 and
266-281 (Figure 3.3A, 3.8A). Interestingly, there was a surface that was primarily
unique to the CtrA dataset, spanning from residues 255-295 and 323-341 (Figure
3.8A,B). We have shown peptides in the region showing strong protection
through peptide uptake plots (Figure 3.8C). This region consists of the loop
connecting the second receiver domain and the GGDEF domain and forms a
surface ideal for binding (Figure 3.8B). This surface shares some overlap with
the surface proposed in the RcdA dataset but does not grossly overlap with the
RcdA surface, suggesting that CtrA and RcdA can both interact with PopA
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simultaneously and provides supporting evidence for ternary complex formation
and different surfaces being involved in the RcdA and CtrA interactions with
PopA. Taken together, the peptides protected in the PopARcdAcdGCtrA dataset
are widely unique to the addition of CtrA compared to the PopARcdAcdG
dataset. Considering both RcdA and CtrA appear to interact with a monomer of
PopA and can form a ternary complex, it is logical for CtrA and RcdA to use
nonoverlapping interfaces on PopA to facilitate ternary complex formation. We
designed a fluorescence polarization-based competition assay to see if CtrA can
compete off RcdA-PopA interactions using a constitutively monomeric variant of
RcdA (RcdA L82E) labeled with Fluorescin-5-Maleimide (Kuhlmann et al., 2021).
Upon incubation of L82E with PopA, we see a characteristic increase in
polarization (Figure 3.11A). Adding an excess of unlabeled RcdA competes off
L82E-PopA interactions by formation of the RcdA-PopA complex, causing the
polarization to return to unbound levels. We tested for competition of L82E-PopA
in the presence of cdG and CtrA and found that CtrA could not compete off
L82E-PopA interactions by formation of the PopA-cdG-CtrA complex (Figure
3.11A). This data suggests that CtrA binding does not overlap with RcdA-PopA
interactions when it is bound to monomers of PopA.
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Figure 3.10: HDX Data from PopA-RcdA-CtrA Ternary Complex

B) Hybrid statistical Woods plot of filtered HDX peptides. Peptides from
each timepoint are shown, with peptides showing lower statistical HDX
change in blue, and higher statistical HDX change in red.
Nonsignificant changing peptides are in grey. This data is the PopARcdA-CtrA-cdG reaction subtracted from the PopA-RcdA-cdG reaction.
B) Mapped HDX changes from the Woods plot onto a SWISS-MODEL
modeled PopA structure based on the inactivated crystal structure of
PleD (PDB code: 1w25). Highlighted in gold is the Rec1-2 stem that
could form a potential surface for CtrA binding. C) Selected peptides
that are highly protected upon CtrA binding from the Woods plot.
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Figure 3.11: Fluorescence Polarization CtrA Competition Assay

A) Fluorescence polarization CtrA competition experiment. Fluorescently
labeled RcdA L82E was incubated with 20uM PopA, RcdA, cdG or
CtrA or in varying combinations. The polarization values were then
read. B) Cartoon illustrated the workflow of the fluorescence
polarization experiment with the different experimental outcomes.
Competition of CtrA leads to a release of the unbound RcdA
fluorophore, causing the polarization to return to unbound levels.
Interaction of CtrA at a different interaction site will not cause the
polarization to return to unbound levels.
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Taken together, our data suggests a model where the delivery of CtrA is
regulated by the formation of a ternary complex of RcdA, cdG, PopA and CtrA
(Figure 3.12). The interaction between PopA and CtrA is gated by cdG binding,
which initiates conformational changes that allow PopA to accommodate CtrA
binding to monomers of PopA. RcdA also binds monomers of PopA, primarily
through interactions with the second receiver domain of PopA. We propose that
CtrA and RcdA interact on nonoverlapping surfaces as shown by HDX and
fluorescence polarization studies and formation of this complex is necessary for
CtrA delivery.

Figure 3.12: Model of PopA-CtrA-RcdA Complex and Delivery Mechanism
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As a monomer, PopA is capable of binding RcdA, cyclic-di-GMP, and CtrA
simultaneously. RcdA-PopA interactions primarily take place at the 2nd receiver
domain, while CtrA interacts with PopA on a different interface. Proper CtrA
delivery is dependent on cdG binding to PopA, which induces conformational
changes that allow for CtrA binding. The formation of this ternary complex is
needed for proper CtrA degradation by the ClpXP protease.
3.4 Discussion
Adaptor mediated degradation is critical for bacteria for coordinating stress
responses and cellular transitions. Because of CtrA critical importance in
regulating the bacterial cell cycle, understanding the mechanisms of binding and
complex formation will advance our understanding of CtrA’s role in
alphaproteobacteria, such as the pathogen Brucella abortus (Francis et al.,
2017). Our HDX and biochemical studies reveal how PopA accommodates RcdA
and CtrA interactions and how cdG gates PopA-CtrA interactions. RcdA and CtrA
do not appear to interact on similar interfaces on the PopA structure.
PopA is a unique protease adaptor in Caulobacter in that it is not degraded like
other adaptors such as CpdR, RcdA and SspB (Joshi et al., 2017), is regulated
by the binding of a small molecule to gate its CtrA delivery function and is limited
to only a small subset of alphaproteobacteria closed related to Caulobacter (Brilli
et al., 2010). Interestingly, CpdR, RcdA and CtrA are present in Brucella abortus,
while PopA is not present (Francis et al., 2017). How Brucella abortus regulates
CtrA post-translationally through degradation remains an outstanding question
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and may be controlled by an adaptor like PopA that fulfills its function through
RcdA interactions. In that case, the fold of PopA, which contains receiver
domains and a cdG-binding site, contains specific elements that allow for proteinprotein interactions through the receiver domains and regulation of activity by
cdG binding. The properties, fold, and functional characteristics of PopA serve as
a model for how unknown adaptors may work in Brucella abortus and other
bacteria that contain the cpdR-RcdA-ctrA pathway. PopA’s evolution from PleD
to fulfill the specific role of delivering cargo in an adaptor-dependent manner is
remarkable. The conversion of PleD, a cdG produced enzyme, to an adaptor that
has no catalytic activity towards cdG highlights the importance of having PopA as
an adaptor that adopts the general fold of a Diguanylate Cyclase yet lacks DGC
activity. Why does PopA need to be able to bind cdG to fulfill its function?
Published literature about DGC’s show that cdG binding shifts the conformation
from an inactive state to an active state and this promotes dimerization of the
enzyme. However, for PopA, this dimerization is very weak and it does not need
to dimerize to promote CtrA binding and delivery. Could there be a role for PopA
dimerization in delivering other PopA-dependent cargo? Recent literature
suggests that there could be a link between PopA dimerization and the protein
SmrF (Wang et al., 2021). One potential model is that PopA adopts both
monomeric and dimeric states to accommodate the delivery of different cargo,
dependent on the local cdG concentration. More work needs to be done to clarify
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the link between cdG and PopA dimerization and how cdG tightly regulates
PopA-dependent activity, regardless of the oligomerization state it is in.
3.13 Materials and Experimental Procedures
Protein Expression and Purification. BL21(DE3) pLYS or X90 cells with
expression plasmids for different proteins were grown at 37°C to an OD600 of 0.40.6, then induced with 0.4mM IPTG for 3-4 h. Induced cells were then centrifuged
at 7,000g for 10 minutes and resuspended in buffer containing 50mM Tris pH 8.0,
300mM NaCl, 10mM imidazole,

0% glycerol, 5mM β-mercaptoethanol and

100mM PMSF and frozen at -80°C until further use. Cells were lysed using a
Microfluidizer system (Microfluidics, Newton, MA). The clarified lysate was bound
over a Ni-NTA column for affinity purification. H6SUMO-tagged proteins were
cleaved by Ulp1-his protease (36). Proteins were then purified using size exclusion
and anion-exchange chromatography using Sephacryl 200 16/60 and MonoQ 5/50
columns. ClpX and ClpP were purified as outlined in (9). Detailed purification
protocols are available upon request.
Cloning and Molecular Biology. PopA variants and trunctations were cloned
using around-the-horn cloning by amplifying the appropriate domains using
pET23SUMO-PopA as a template.
Fluorescence Polarization and Maleimide Labeling. Purified RcdA or RcdA
mutants were labeled with Fluorescin-5-Maleimide (Thermo ScientificTM). Purified
protein at ~8-10 mg/mL was buffer exchanged into labeling buffer (50 mM Tris pH
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7.0, 150mM NaCL, 2mM TCEP). Fluorescin-5-Maleimide was dissolved in DSMO
and added to protein at a 20-fold molar excess to cysteine. Labeling reactions were
completed at 4°C overnight. Free dye was removed using a PD-MidiTrap column
(GE Healthcare) and Amicon Ultra-15 Centrifugal Filter Units in a buffer containing
20mM HEPES pH 8.5, 100mM KCL, 10mM MgCl2 and 0.05% Tween.
Confirmation of protein labeling was verified using a Typhoon imaging system (GE
Healthcare). The labeled protein was aliquoted, and flash frozen at -80°C.
Fluorescence polarization binding experiments were performed with 100 nM
labeled RcdA or RcdA L82E and varying concentrations of PopA, CtrA or cdG. The
binding reaction was incubated at 25°C for 1hr to reach equilibrium. Polarization
measurements were read from 40uL of these mixtures using opaque black 384well plates using a SpectraMax M5 plate reader (Molecular Devices) with excitation
and emission wavelengths set at 460 and 540, respectively. Equilibrium binding
constants were calculated by fitting the polarization data using GraphPad Prism to
a one site, total and nonspecific binding equation P = Pmax*[X]/([X] + K d) where
Pmax is the maximum specific binding value, P is the polarization value, NS is the
slope of linear nonspecific binding constrained to be greater than 0, and the
background is the polarization value when [X] is 0. The NS term usually fits to 0
and is not included in the final fit. Error bars are calculated from the standard
deviation between replicates of experiments. All RcdA concentrations are in terms
of monomeric equivalents unless otherwise noted.
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Size-Exclusion Chromatography with Multi-Angle Light Scattering. Each
protein complex was allowed to bind at room temperature for 45 minutes. The
complexes were then injected onto a T Kgel™ G3000

EC column equilibrated

in 20mM HEPES buffer, pH 7.0 with 100mM KCL and 10% glycerol (Tosoh
Biosciences) at room temperature. The SEC column was coupled to an 18-angle
light scattering detector (DAWN HELEOS-II) and a refractive index detector
(Optilab T-rEX) (Wyatt Technology). Data was collected every second and the flow
rate was set to 0.5 mL/min. Data analysis was carried out using the program
ASTRA (Wyatt Technology). Monomeric bovine serum albumin (BSA; Sigma) was
used for calibration of the light scattering detectors and general data quality
control. Measurements were taken at 25°C. The light scattering data was collected
across a window containing the entire chromatographic peak for a full distribution
of molecular weights, shown underneath each chromatogram.
Hydrogen-Deuterium Exchange Mass Spectrometry. Hydrogen-deuterium
exchange was measured on a Synapt G2Si high definition mass spectrometer
(Waters). Deuterium exchange and quenching steps were performed using an
automated HDX robotics platform (Waters). Samples were diluted 1:16 in D2Ocontaining buffer containing 0.1 mM K2HPO4 to final concentrations as specified in
the figure legends. Deuterium exchange was allowed to take place for 0, 1, 10 and
60 minutes at 25°C, with staggered starts for each dilution reaction. After all
reactions were completed, aliquots were removed and diluted 1:2 into cold quench
buffer at 4°C (water with 4M Guanidine Hydrochloride at pH 2.5) and
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subsequentially run over an immobilized Water ENZYMATE immobilized pepsin
column (ID: 2.1 length: 30mm) at a flow rate of 0.15mL/min at high pressure
(~11000 psi) for peptide digestion. Prior to HDX analysis, the quality of each
sample was assessed using SDS-PAGE and size-exclusion chromatography. The
output peptides were filtered using DynamX using the following filtering
parameters: minimum intensity of 1000, minimum and maximum peptide sequence
length of 5 and 30, respectively, minimum MS/MS products of 2, minimum products
per amino acid of 0.25 (this can be further adjusted to prune peptides), minimum
score of 5, and a maximum MH+ error threshold of 5 p.p.m. After analysis in
DynamX, the data was exported as a cluster file for further analysis using
Deuteros. For statistical analysis, filtering of peptide uptake plot data was
performed in Deuteros (Hageman and Weis, 2019, Lau et al., 2020) using a Hybrid
statistical model for the woods plot with ɑ = 0.02 for PopA-cdG HDX and ɑ = 0.05
for all other experimental datasets. Mapping of Deuteros filtered data was
performed using a pymol script exported from the Deuteros woods plot and
mapped onto a modeled structure of PopA based on the inactive structure of PleD
(Two independently prepared experimental replicates and labeling reactions were
performed for each condition and averaged in the peptide uptake plots. Blank runs
were run in between each analysis to avoid peptide carry-over. Continuous lockmass correction was performed using leu-enkephalin compound. Timepoints and
analysis were randomized to ensure no biasing of results and to ensure variation.
Peptides were ionized and separated by electrospray ionization for analysis in
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MSE mode at a mass resolution of 50-2000 m/z range. Identification of peptides
and analysis of the uptake plots and charge states for each peptide were
completed in Protein Lynx Global Server (PLGS) and the software DynamX
(Waters). Uptake plots were plotted and created in Adobe Illustrator and in
GraphPad Prism.
In vitro Degradation Assays. Degradation of GFP-CtrARD+15 was monitored
with the loss of fluorescence over time as described previously (Smith et al., 2014).
The concentrations of each protein used in the reactions were as follows unless
otherwise noted: 3μM RcdA, 3μM RcdA(L82E), 2μM CpdR, 0.2μM ClpX6, 0.4μM
ClpP14, 2μM GFP-CtrARD+15, 5mM ATP. GFP-CtrARD+15 with cdG curves were
fit to a modified hyperbolic equation with the form of: Y = ((Vmax * [RcdA]) / (K act
+ [RcdA])) + A, where A is a baseline constant, or to the Michaelis-Menten equation
using GraphPad Prism.
Sedimentation Velocity Analytical Ultracentrifugation. Sedimentation Velocity
experiments were completed using a Beckman ProteomeLab XL-1 Analytical
Ultracentrifuge (Beckman). Samples were diluted into 20 mM HEPES pH 8.5,
100mM KCl, 10% glycerol at the concentrations indicated in the figure legends.
The samples were spun at 55,000 g overnight at 25°C. The ρ and v values used
for data fitting were determined using SEDNTERP and the amino acid sequence
for each protein. The sedimentation velocity data was directly fit to the c(s)
distribution method using the program SEDFIT and using the first 100 velocity
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scans for each condition. The resulting distributions from each experiment were
then plotted in GraphPad Prism.
Ni-NTA Nickel Pulldown Assays. Nickel pulldown assays were performed using
a Ni-NTA resin (Thermo Scientific). 50µL of Ni-NTA resin was washed and
equilibrated with 200µL wash buffer (20mM Hepes pH 8.5, 100mM KCL, 10%
glycerol, 30mM Imidizole). Each protein or protein mixture was combined at 200µL
final volume and added to resin to incubate at 4°C for 2 hours. The Ni-NTA resin
was spun down at 700xg for 2 minutes and the flowthrough samples were
collected. 200µL of wash buffer was then added and a 700xg spin was performed
again with a wash sample taken after the spin. Finally, 200µL of elution buffer
(20mM Hepes pH 8.5, 100mM KCL, 10% glycerol, 300mM Imidazole) was added
to the resin and spun down with the collection of an elution sample taken after the
spin. Each sample was then run on SDS-PAGE gels for analysis.
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Bacterial Strains Used in This Study:
Organism
E. coli

Name
TOP10
BL21(DE3)
pLysS
X90 T7
EPC100
EPC112

EPC162

BPC238
EPC196

EPC970

EPC1000
EPC1037

EPC1517

EPC520

Description
Cloning strain
recombinant
protein expression
recombinant
protein expression
dh5alpha pQE70his-ClpP
BL21DE3 pLysS
pET23 Ulp1his
protease
BL21DE3 375
eGFP-His6CtrARD+15
BL21DE3 plysS
pET23 ClpX
BL21DE3 plysS
pET23b
His6Sumo-CpdR
BL21DE3 plysS
pET23b
His6Sumo-RcdA
TOP10 pET23b
His6Sumo-RcdA
BL21DE3 plysS
pET23b
His6Sumo-PopA
BL21DE3 plysS
pET23b
His6Sumo-RcdA
L82E
Pet28-His6CtrA
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Source
Invitrogen
Invitrogen
From Bob Sauer
(Chien et al.,
2007)
This study

(Smith et al.,
2014)
(Chien et al.,
2007)
(Lau et al., 2015)

(Joshi et al.,
2015)
(Joshi et al.,
2015)
(Joshi et al.,
2015)
Kuhlmann et al.,
2021

This Study
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Chapter 4
Future Perspectives and Impact of Thesis on the Adaptor Field
4.1 Overview
In this chapter I will explore future directions that I think are worth exploring for
the field of protease adaptors. The fundamental, mechanistic work on RcdA and
PopA function that my thesis is focused on will allow for further dissection on the
details of adaptor-mediated proteolysis in Caulobacter and other bacteria. The
mechanistic work that my thesis is focused on will provide tools to solve further
research questions about the ClpXP adaptor hierarchy. I will discuss the lessons
and perspectives about adaptors and adaptor-mediated protein degradation that I
have gathered throughout my Ph.D. and its impact to the adaptor field. Finally, I
will discuss future avenues of research that are of particular interest to me and
will further our basic understanding of adaptor-dependent proteolytic pathways.
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4.2 Impact of Thesis Work on Protease Adaptor Field
My thesis built on the work and the fundamental observation that adaptors can
work synergistically to provide additional layers of regulation to protein
degradation during critical cellular stages of growth and development (Joshi et
al., 2015). Furthermore, my thesis work expanded on the initial observation that
when an adaptor protein is not actively performing its delivery function, it is
actively degraded by the protease (Joshi et al., 2017). However, these
observations did not fully explain how each of the adaptors serve their regulatory
role and why adaptor degradation matters in vivo. The composite work of my
mechanistic studies of RcdA and PopA demonstrates that in addition to the basic
function of an adaptor choosing specific substrates by acting as a scaffold, cellcycle specific adaptors such as RcdA and PopA possess additional layers of
regulation that are needed to tune the activity levels of each adaptor during the
cell-cycle, and in the case of RcdA, this additional layer of regulation also
controls its proteolytic stability. RcdA’s regulation of activity and degradation is
linked through dimerization by acting as an inhibitory role against prolific RcdA
activity. The work presented in Chapter 2 was the first demonstration of adaptor
dimerization having a direct consequence on its stability and this stabilization
having a physiological consequence, as adaptor degradation has been observed
in other bacteria (Puri et al., 2017, Turgay et al., 1998) but not elaborated upon.
This piece of information can perhaps lend itself to future studies of adaptor
stability and its contribution to cell viability in other organisms by looking for
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determinants of adaptor degradation, modifying those determinants, and looking
for changes in cell viability or physiology. Perhaps even more fascinating
concerning adaptor degradation in Caulobacter crescentus is that PopA does not
get degraded, while CpdR and RcdA are degraded robustly (Joshi et al., 2017).
What properties about PopA prevent its self-degradation that CpdR and RcdA do
not have, and why is PopA not found in every organism that contains CtrA, such
as Brucella abortus? A possible explanation is that the constitutive presence of
PopA is necessary for proper timing of the delivery of CtrA during the cell-cycle,
while for CpdR and RcdA and their respective substrates this is not a
requirement. Further studies elaborating on the specifics of CpdR degradation
and consequentially their effects on cell viability and substrate delivery would
help clarify the overall significance of adaptor degradation not only in
Caulobacter, but in all organisms that use adaptors as protease regulators. The
specific studies needed for RcdA characterization might not generalize to other
adaptors and for me, personally, this is an aspect of adaptors that should be
explored further in the field to really understand the significance of adaptors in
maintaining cell physiology. These types of studies would lend themselves well in
organisms such as Caulobacter that have distinct developmental transitions or
stress responses that are aided by adaptor-mediated protein degradation.
The finding that RcdA reserves different aspects of its dimerization interface for
different cargo provides further understanding for how an adaptor that has a pool
of cargo to deliver can accommodate different classes of substrates. By sharing
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a common interface, specificity is achieved by tailoring different aspects of the
interface to different classes of cargo. The RcdA pulldown data (Joshi et al.,
2015) suggested a large range of otherwise uncharacterized RcdA interacting
partners. It is possible that RcdA represents a general adaptor specifically
evolved to fulfill the role of delivering dozens of substrates during the cell-cycle
that have no shared similarities, functions, or structures. In this case, the
experimental approaches outlined in Chapter 2 would help identify the overlap
between different classes of cargo: some cargo might interact at the SpbR/TacA
site, while others might interact at the PopA site, including as-of-yet to be
discovered adaptor proteins. Using mutants such as the RcdA L82E or RcdA 3E
could be used to filter out false positives. For organisms that undergo specific
developmental transitions that are accompanied by coordinated protein
degradation by adaptors, having a general adaptor that can degrade several
classes of cargo such as RcdA allows the cell to preserve energy by not requiring
many different adaptors to be synthesized. Other bacteria that undergo
morphological differentiation that is dependent on protein degradation might
make use of an adaptor that contains a large interface that is tailored to
accommodate different varieties of cargo. In contrast, bacteria that do not
undergo distinct morphological transitions during their life cycle, such as E. coli,
use adaptors such as SspB and RssB have a limited range of cargo in
comparison to RcdA. The use of a smaller, more specific interaction site fits the
purpose of those adaptors more appropriately.
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PopA represents a different adaptor than RcdA in that its delivery activity is
regulated by a small molecule, rather than oligomerization. It was hinted that
PopA dimerization might be important in vivo (Wang et al., 2021). However, the
data presented in Chapter 3 suggests that binding of cdG to PopA allows for
conformational changes in PopA to accommodate CtrA binding and delivery
independent of PopA dimerization, as concentrations of PopA and cdG that
promote full delivery and binding of CtrA do not induce dimerization. Binding of
cdG accomplishes the same purpose of the dimer interface of RcdA: to gate CtrA
delivery activity of PopA only when it is necessary. For the adaptors in the ClpXP
adaptor hierarchy, an additional layer of regulation for each adaptor is present,
whether it is phosphorylation of CpdR, dimerization of RcdA, or cdG binding to
PopA. Each adaptor in the hierarchy is mechanistically and structurally diverse
from each other, yet a need exists for gated activity because of the role each
adaptor plays in the Caulobacter cell cycle. One interesting fact is that PopA
does not exist in other bacteria and is only present in closely related
alphaproteobacteria to Caulobacter (Brilli et al., 2010). However,
alphaproteobacteria such as Sinorhizobium meliloti and Brucella abortus contain
the CtrA gene network (including CpdR and RcdA) yet do not possess PopA. In
the case of Sinorhizobium meliloti, the proteolysis of CtrA is essential for proper
cell morphology and this proteolysis is dependent on CpdR and RcdA and
perhaps an unknown adaptor that fulfills the role of PopA (Pini, et al 2015). My
basic studies on how PopA is regulated and how PopA interacts with RcdA and
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CtrA will hopefully develop a template for how an unknown adaptor that is
necessary for CtrA degradation might function in other organisms. This would
potentially lend itself well to a screen for RcdA and CtrA binders, as the
interaction surfaces and specific folds PopA adopts might be similarly evolved in
a different protein to serve the same function for CtrA degradation.

My thesis provides insight into how adaptor activities can be gated by additional
layers of regulation, depending on the need for the adaptor in the cell. My
specific studies of PopA and RcdA identify key characteristics of each adaptor
that are critical to its function and provide a framework for how the basic
interactions and determinants between RcdA and PopA might function in other
organisms. The future of the adaptor field will likely be influenced by the
development of genetic and proteomic screens to reliably identify new adaptorsubstrate pairs that regulate critical stress responses and developmental
transitions in pathogenic bacteria to identify which adaptors could be targeted as
avenues for antibiotic drug discovery. The remainder of this chapter will discuss
future avenues of adaptor research that are of particular interest to me.
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4.3 CryoEM characterization of the ClpXP Adaptor Hierarchy
Recent Cryo-EM structures of the ClpXP machinery have uncovered critical
information regarding the fundamental mechanism of ClpXP activation and
substrate interactions (Gatsogiannis et al., 2019, Fei et al., 2020, Bell et al.,
2020). However, these CryoEM studies were limited to variants of ClpX lacking
the N-terminal domain, the part of ClpX that is necessary for CpdR interactions
and adaptor-mediated protein degradation (Lau et al., 2015). Therefore,
mechanistic insight into how the adaptor hierarchy structural forms and performs
its function is sorely lacking as of now. During my Ph.D., I was part of a 3-year
collaboration with Gabe Lander’s lab to solve CryoEM structures of the adaptor
hierarchy. Unfortunately, we have not been able to solve the CryoEM structure of
any of portion of the adaptor hierarchy that involves ClpX with its N-terminal
domain intact and in the presence of other adaptors. While we made progress in
forming stable adaptor-protease complexes suitable for CryoEM analysis, more
work is necessary to produce enough of these ternary complexes for CryoEM.
Even a CryoEM structure of native ClpXP bound to CpdR would inform a great
deal on the composite interface that is hypothesized to be necessary for CpdRmediated degradation (Lau et al., 2015). Furthermore, a native CryoEM structure
of ClpXP with adaptors bound will help explain how any potential avidity effects
help aid in degradation. For the case of RcdA, my thesis work and the previous
work on RcdA completed by Dr. Kamal Joshi describe the mechanism of RcdA
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degradation in detail, but do not fully explain why all these adaptors are
necessary for recruiting their substrates for ClpX recognition and degradation. An
atomic snapshot of ClpXP with CpdR, RcdA and their respective cargo would
elucidate how the adaptor hierarchy accomplishes this handoff and the
interactions that facilitate this sequence of events. The primary challenge is
obtaining stable, highly concentrated Adaptor-bound complexes needed for
CryoEM. Chemical crosslinking and using a small SEC column that prevents
dilution, along with more optimized purification protocols for ClpX to increase
yield, are necessary to move this project forward. The concentration of is the
limiting factor in getting high quality samples, as ClpP, CpdR, and RcdA are all
very soluble at high concentrations, while concentration of ClpX results in drastic
loss of protein in a spin concentrator. Using different expression systems and
purification schemes to increase ClpX yield would speed up preparing highly
soluble, concentrated samples necessary for CryoEM. The value of having such
a CryoEM structure would answer questions about how the delivery mechanism
of an adaptor-mediated substrate, such as PdeA, TacA or SpbR, is determined
by the collective interactions between adaptors and protease.
4.4 Structural characterization of RcdA-Cargo Interactions
My HDX-MS studies highlighted two surfaces that, by mutagenesis, were
mutually exclusive for direct RcdA cargo and other adaptors like PopA. However,
due to the limited resolution of HDX, we cannot assign atomic-level information
on the RcdA-cargo interaction surfaces. To fully understand how cargo binding
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causes RcdA to dissociate into monomers, a crystal structure of RcdA bound to
cargo is needed. In the past, we have tried to crystallize RcdA bound to SpbR
and TacA as a co-crystal complex, but that came with its own issues. The RcdA
homodimer appears to crystallize more readily than the RcdA-cargo complex,
and the binding affinities of dimerization and cargo binding are similar, making
crystallization of native RcdA-cargo complexes challenging. Because the L82E
variant does not dimerize and can bind PopA with affinities like native RcdA, a
viable approach would be to solve a structure of L82E bound to PopA or bound
to the receiver domains responsible for interacting with RcdA. Furthermore, NMR
structures of the L82E variant bound to the receiver domains of PopA might be a
viable approach for mapping RcdA-cargo interactions at the atomic level.
4.5 Mechanistic Characterization of CpdR Function
CpdR is responsible for the regulated degradation of all known cell-cycle
dependent ClpXP substrates (Lau et al., 2015). The biological consequences of
mis regulation of CpdR function are distinct, causing motility defects and loss of
ClpX localization to the cell poles (Lau et al., 2015). While it seems clear that
CpdR must prime ClpX for degradation of its substrates, mechanistic
characterization of these interactions and how this specificity is achieved remains
unclear. Several remaining questions and obvious experiments could possibly
shed insight into this question. It seems clear that the interaction of CpdR and
ClpX is necessary for degrading CpdR-dependent substrates. How does this
interaction happen? HDX-MS studies of the CpdR bound to ClpX and substrate,
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using purified proteins or a linked complex with native ClpX or just the NTD,
would help explain this observation. Furthermore, NMR studies of CpdR bound
the NTD would help identify the interface that CpdR binds to. Mutagenesis of
residues that are identified in these datasets would help confirm these interfaces.
Finally, limited proteolysis of a linked CpdR-NTDClpX or even a linked RcdACpdR-NTDClpX complex could also be an approach to identify regions that are
more resistant to proteolysis, suggesting protein-protein interaction surfaces. ITC
or Fluorescence Polarization studies of CpdR-NTDClpX would help aid in these
studies to determine binding affinities and stoichiometries. CpdR could also be
negatively regulated by dimerization through an active, unphosphorylated
conformation. In this model, phosphorylation of CpdR leads to dimerization and
inhibition of CpdR activity. Interestingly, The D9G mutant appears to form less
higher-molecular weight aggregates during SEC purification (Christine Battle,
unpublished data), suggesting that this variant may have differences in
oligomerization. SEC-MALS or AUC using the D9G variant, a
nonphosphorylatable CpdR variant (CpdR D51A) or using native CpdR in the
presence of the phosphorelay system might help elucidate this mechanism of
activation by dimerization.
4.6 Identification of New Adaptor-Dependent Substrates and Pathways
Discovery of new adaptors and adaptor-substrates pairs is a circular problem.
We identify adaptor function by showing enhanced degradation of a substrate,
but that approach only works if we know the substrate beforehand. In the case of
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TacA and PdeA, prior knowledge from a ClpP trapping experiment identified
these proteins as ClpXP substrates prior to our labs discoveries as CpdR and
RcdA as their respective adaptors (Bhat et al., 2013). Biochemical reconstitution
of these adaptor-substrate pairs confirmed the enhancement of PdeA and TacA
degradation (Lau et al., 2015, Joshi et al., 2015). However, more systematic
approaches for identifying new adaptor-substrate pairs are needed. Our labs
recent optimization of systems biology approaches such as Transposon
Sequencing (Tn-seq) and Tandem Mass Tag Proteomics (TMT) will provide a
roadmap to developing methods for identifying new adaptor-substrate pairs and
adaptor-dependent pathways. For example, particular adaptor variants that
change adaptor function (such as RcdA L82E, RcdA 3E, CpdR H106A, CpdR
R69A, PopA R357G) all contain specific changes in their activity that result in
specific changes in substrate delivery and morphology. Along with adaptor
deficient strains (ΔcpdR, ΔrcdA, ΔpopA), making strains containing these
mutations would allow for optimal controls for identifying changes in our adaptor
deficient strains, as we know that RcdA L82E and RcdA 3E contain substrate
binding deficiencies, and PopA R357G cannot deliver CtrA during the cell cycle
due to loss of cdG binding (Duerig et al., 2009). For example, to identify a
potential new RcdA binding partner, deletion of RcdA show result in an increase
in protein abundance of a particular candidate by TMT. If the RcdA L82E showed
no change in that substrate’s abundance, but the RcdA 3E showed a relative
increase in that protein’s abundance, then it could be concluded that changes in
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the abundance of that substrate are due to RcdA binding at the surface
implicated in PopA binding and it would make it much easier to identify highly
specific RcdA binders. The same approach could be used for CpdR and PopA to
identify new substrates by TMT. Identifying new adaptor-dependent pathways
could follow a similar roadmap: adaptor deficient strains will likely see changes in
the insertion profile of many substrates. If that insertion profile is differentially
affected in one RcdA variant versus another, then it could be concluded that
RcdA is involved in this pathway. If it is found that upon purification of candidates
that show a change in insertions are not enhanced in their degradation upon
addition of adaptor, then a potential novel role for an adaptor in that pathway
independent of enhancing proteolysis could be hypothesized. The use of adaptor
variants could potentially help weed out potential false positives amid the large
quantity of TMT and Tn-seq data, allowing for the pruning of a few promising
candidates.
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APPENDIX
Uncropped Gels and Blots used for Figures in Chapter 2

Figure A.1: Uncropped Degradation Gels, Related to Figure 2.11
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Figure A.2: Uncropped Degradation Gels, Related to Figure 2.14,
Figure 2.23
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Figure A.3: Uncropped Western Blots, Related to Figure 2.26
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Additional Biochemical Data
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Figure A.4: The RcdA R131/5E Variant is Dimeric
SEC-MALS analysis of the R131/5E variant compared to WT RcdA. Both proteins
were run over the column at 25uM. Dotted lines indicated collected MALS data
and calculated mass. The R131/5E mutant was designed to disrupt the
crystallographic dimer interface of our in-house solved crystal structure of RcdA,
but that interface was shown to be the incorrect interface. The dimer interface
described in (Taylor et al., 2009) is the correct dimer interface of RcdA.
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Figure A.5: The RcdA L82A Variant is Dimeric
SEC-MALS analysis of the L82A variant compared to WT RcdA and RcdA L82E
(RcdA and L82E SEC-MALS Data is from Figure 2.10). Dotted lines indicated
collected MALS data and calculated mass. The L82A variant did not scatter light
in this experiment, but coeluted perfectly with WT RcdA, suggesting dimerization.
The L82A mutant was designed to test whether we could form an obligate
monomer of RcdA that did not affect cargo binding or delivery. This data tells us
that the presence of L82 is not necessary for dimerization, as mutation to another
hydrophobic residue of different atomic geometry does not disrupt dimerization.
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Figure A.6: RcdA Monomerization is Not Detectable by SEC-MALS
Serial Dilutions of RcdA were ran over the SEC-MALS column. At the
concentrations detectable by absorbance, RcdA monomerization was not able to
be determined by SEC-MALS. This describes a key limitation to SEC-MALS: the
light scattering signal is proportional to the concentration of your injected protein,
it becomes challenging for proteins of smaller mass to design SEC-MALS
experiments at lower concentrations.
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Figure A.7: RcdA Monomerization is Not Detectable by SV-AUC
Different concentrations of RcdA were ran on the analytical centrifuge and
analyzed by sedimentation velocity. At the concentrations detectable by
absorbance, an RcdA monomer-dimer equilibrium was not observed in the c(s)
distributions provided by SV-AUC.

Since

we

could

not

detect

RcdA

monomerization by absorbance detection, we decided to use a fluorescent reporter
(Fluorecin-5-maleimide RcdA) and isothermal titration calorimetry to monitor RcdA
dimerization more sensitively.
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Figure A.8: HSQC NMR Spectrum of RcdA-DBDTacA interaction
Early in my graduate career, we collaborated with the Strieter lab to perform protein
NMR studies (Lin Hui, Eric Strieter) to see if we could possibly elucidate the binding
site of RcdA to DBDTacA. While we did see changes in the peak assignments when
DBDTacA

was added (inset), we were unable to determine the final binding site.

Repeating this experiment with the RcdA L82E variant with PopA truncations
(receiver1-2) would likely yield cleaner results.
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Figure A.9: Schrodinger-Modeling TacA Peptide on RcdA Crystal Structure
The original identification of the RcdA 3E residues was through Schrodinger
modeling (collaboration with Sergey Savinov) of a TacA peptide on our in-house
solved structure of RcdA, which revealed a “pocket” that was proposed as
important for ligand binding. In purple is the modeling TacA peptide, while in red
sticks are the residues of the RcdA 3E mutant: R49, K53, R57. These residues
were mutated to glutamic acids by Ashley Kosowicz, a previous undergraduate in
the lab, to make the original RcdA 3E expression plasmid.
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Figure A.10: Intrinsic Tryptophan Fluorescence Scans of RcdA and RcdA
L82E
Intrinsic Tryptophan Fluorescence Profiles of RcdA and RcdA L82E in the absence
or presence of denaturant (5M Guanidine Hydrochloride). In the presence of
GuHCL, both RcdA and RcdA L82E shift in λmax (330nm to 350nm), indicating the
unfolding of the protein. Interestingly, upon unfolding, the fluorescence of RcdA
L82E increases relative to the native state, while the fluorescence of RcdA
decreases relative to the native state. The intrinsic tryptophan fluorescence per
monomeric concentration unit of RcdA L82E is lower than that of RcdA at equal
monomeric concentrations of protein.
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Figure A.11: The RcdA 3E Variant does not form a Heterodimer by
Fluorescence Polarization
Fluorescence polarization looking at heterodimerization of fluorescently-labeled
RcdA with unlabeled RcdA variants. Assays were performed exactly as described
earlier, with 20uM of unlabeled RcdA 3E, RcdA 131/5E, PopA and RcdA added to
100nM labeled RcdA. The only variant to not show an increase in polarization was
the RcdA 3E variant, which did not show a characteristic increase in polarization
when added. Unlabeled PopA and RcdA were used as positive controls in this
assay.
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Figure A.12: Differential Scanning Fluorimetry Melt Curves of RcdA
Variants
DSF melt curves of various RcdA variants at 10uM final concentration. Melt curves
were generated as described in appendix methods. Fitted Tm values are listed
above the dotted line for each variant. The RcdA 3E and RcdA R131/5E variants
are destabilized relative to WT RcdA as observed by their lower Tm values.
Interestingly, the RcdA L82E monomer did not produce a melt curve or show a
steady increase in fluorescence as the protein was heated, indicating that the
Sypro orange fluorescent dye was incompatible or could not bind due to the RcdA
L82E mutation.
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Figure A.13: ITC Thermogram of L82E-PopA Interaction
ITC Thermogram of 400µM L82E titrated into a pool of 40µM PopA. Both proteins
were purified into 20mM Hepes, pH 8.5, 100mM KCL over an S200 size-exclusion
column prior to injection. Data was fit to a single set of sites binding model.
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Figure A.14: GFP-DBDTacA Assays in the Presence of PopA-RD1 truncation
(aa 1-117)
GFP-DBDTacA fluorescence degradation assay in the presence of different
concentrations of PopA-RD1. 1µM GFP-DBDTacA 1µM RcdA, 4µM CpdR, 0.2µM
ClpX, 0.4µM ClpP, and varying concentrations of PopA-RD1 were used in this
assay.
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Figure A.15: CpdR-ClpX Binding Curves with L82E and RcdA Fluorescent
Reporters
ClpX-CpdR interactions using a fluorescent RcdA or RcdA L82E Reporter. 1µM
ClpX, 1mM ATPyS, 100nM FL-L82E or RcdA and varying concentrations were
used. A single site binding model was used to fit the data in prism as outlined in
the methods of Chapter 2.

181

Figure A.16: CpdR Kactivation Curve with GFP-DBDTacA
GFP-TacADBD fluorescence degradation assay in the presence of different
concentrations of CpdR. 1µM GFP-DBDTacA, 1µM RcdA, 0.2µM ClpX, 0.4µM ClpP,
and varying concentrations of CpdR were used in this assay. Data was fit to a
modified form of the Michaelis-Menten equation as noted in the methods of
Chapters 2 and 3.
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Additional In Vivo Data

Figure A.17: Agar Motility Assay of PrcdA::L82E and PrcdA::RcdADD, related
to data presented in Figure 2.28
While generating the PrcdA::L82E strain, we looked for phenotypes that might be
used to screen for positive mutants.

ince we know that ΔrcdA strains have a

motility defect, we used motility as a readout of positive strain construction.
Interestingly, the PrcdA::L82E has a defect in motility while the PrcdA::RcdA and
PrcdA::RcdADD strains do not have motility defects, suggesting that the motiltity
phenotype is likely linked to deficiencies in cargo delivery due to the L82E
mutation, not RcdA autodegradation.
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Figure A.18: CtrA Synchrony assay of PrcdA::RcdADD
Before we generated the PrcdA::L82E strain, we hypothesized that RcdADD might
deliver substrates faster in vivo because of its prolonged time on the CpdR-ClpX
complex due to its inability to be degraded. The PrcdA::RcdADD strain was capable
of delivering CtrA to ClpXP more quickly throughout the cell cycle. Shown on the
left is a representative western blot of this timecourse and on the right is the
quantification of this western blot, normalized to the ClpP control band.
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Figure A.19: PrcdA::RcdADD Competition Fitness Assay
Fitness competition assay between wildtype and PrcdA::RcdA or PrcdA::RcdADD.
Like Figure 2.28D, the wildtype and ΔrcdA data are the same controls used.
Average and standard deviation of three independent replicates is shown.
Competition assays were completed as noted in Chapter 2 methods section.
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Figure A.20: Phosphomyocin Spot Assay of Adaptor Deficient Strains
Upon characterization of RcdA-dependent phenotypes, we found that addition of
the cell wall stressor that targets MurA, Phosphomyocin, caused viability defects
on an agar plate. Shown is a spot assay of ΔrcdA and ΔpopA strains on PYE and
on PYE + 0.0025mg/mL of Phosphomyocin.
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